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CHAPTER 1 
ABSTRACT 
LOCAL AND SYSTEMIC ACTIONS OF GnRH RELATING TO ESTRADIOL AND 
ASSOCIATED REPRODUCTIVE PARAMETERS IN BEEF CATTLE 
JERICA J. J. RICH 
2017 
 In cattle, estradiol is responsible for modulating many mechanisms involved in 
successful reproduction.  Specifically estradiol is the primary signal for the initiation of 
standing estrus (Allrich, 1994), and cattle expressing estrus prior to fixed time AI (FTAI) 
have been reported to have increased preovulatory estradiol concentrations (Perry and 
Perry, 2008) and increased pregnancy success compared to animals that did not exhibit 
estrus (Richardson et al., 2016).  Gonadotropin releasing hormone, classically, stimulates 
estradiol production via the two-cell two-gonadotropin hypothesis (Fortune and Quirk, 
1988), and GnRH administered systemically in small doses (5 μg) has been reported to 
elicit an LH pulse similar to a physiological pulse (Ginther et al., 1996).  In a study where 
multiple small doses (5 μg) of GnRH were administered following CIDR removal, 
concentrations of estradiol were increased (Larimore et al., 2016).  These studies 
demonstrate that estradiol production from ovarian follicles could be stimulated with 
systemically administered GnRH.  In addition, to the classical pathway, GnRH receptor 
mRNA has been characterized in bovine granulosa cells (Ramakrishnappa et al., 2003), 
and GnRH has been reported to have local stimulatory and inhibitory actions on 
steroidogenesis within the ovary (Sharpe, 1982; Janssens et al., 2000).  The role of GnRH 
in bovine follicles as it pertains to estradiol production and/or the regulation of estradiol 
production has not been well characterized.  Therefore, the objective of the subsequent 
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studies were to investigate the relationship of GnRH and its impact on estradiol 
production and other reproductive parameters by conducting field trials where GnRH was 
administered systemically (Chapters 3 and 4), as well as the local abundance of GnRH-I 
and GnRH-II mRNA within granulosa cells of bovine antral follicles (Chapter 5).  
 In Chapter 3, beef cows and heifers (n = 1620) were synchronized using the 7-day 
CIDR protocol, and randomly assigned to one of three treatments (0, 5, and 10 µg of a 
GnRH analog at CIDR removal).  Animals were visually observed for estrus and 
inseminated following detection in estrus.  Interval to estrus was calculated for each 
animal that exhibited estrus (INTERVAL 1).  Animals that did not exhibit estrus were 
given 100 μg of GnRH at the time of AI and their interval to estrus was designated at 120 
h (INTERVAL 2).  There was an effect of age (P < 0.01) and a treatment by age 
interaction (P = 0.05) on INTERVAL 1.  Heifers had a shorter interval to estrus than 
cows (50 h vs 54 h respectively).  Furthermore, heifers given 5 μg of GnRH tended to 
have a shorter interval to estrus (P = 0.07; 47 ± 1.4 h) compared to 0 μg (50 ± 1.5 h) and 
did have a shorter interval compared to 10 μg (P < 0.01; 52 ± 1.5 h).  There were no 
differences among treatments in interval to estrus among cows (P ≥ 0.34).  When animals 
that did not exhibit estrus were included in the analysis at 120 h there was no treatment 
by age interaction (P = 0.49).  This is likely due to the fact that treatment (P < 0.01), but 
not age (P = 0.96) or treatment by age (P = 0.74) influenced expression of estrus, with 5 
μg tending to have more animals in estrus (P = 0.10; 79 ± 4%) compared to 0 μg (74 ± 
5%), and 10 μg having fewer animals in estrus compared to either other treatment (P < 
0.04; 68 ± 6%).  Estrus (P < 0.01) and age (P < 0.01) influenced pregnancy success with 
heifers having greater pregnancy success compared to cows (49 ± 5% vs 38 ± 4%, 
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respectively) and animals exhibiting estrus having greater pregnancy success compared to 
animals that did not exhibit estrus (57 ± 4% vs 32 ± 4%, respectively).  However, there 
was no difference in pregnancy success between treatments among animals that exhibited 
estrus (P > 0.30).  Among animals that did not exhibit estrus 0 μg had increased 
pregnancy success (P ≤ 0.05; 40 ± 6%) compared to 5 μg and 10 μg which did not differ 
(27 ± 6% and 29 ± 5%, respectively).  This experiment demonstrated that small doses of 
GnRH following CIDR removal can shorten the interval to estrus and increases the 
percentage of animals exhibiting estrus prior to AI. 
 In Chapter 4, beef cows and heifers (n = 247) were synchronized using the 7-day 
CO-Synch + CIDR protocol and were assigned to one of three treatment groups [0 µg 
GnRH at CIDR removal (0 µg); 10 µg GnRH at CIDR removal (10 µg), or 5 µg at CIDR 
removal plus 5 µg 12 h later (5 + 5 µg)].  Animals were visually observed for estrus and 
artificially inseminated 55 (heifers) or 60 (cows) hours following CIDR removal (FTAI).  
Blood samples were collected beginning at CIDR removal and every 12 hours until time 
of AI.  Concentrations of estradiol were not influenced by treatment (P = 0.66) or a 
treatment by time interaction (P = 0.87), but were influenced by time (P < 0.0001).  
Estradiol concentrations increased from CIDR removal to 48 hours after CIDR removal 
and then were decreased at the time of AI.  Expression of estrus was not influenced by 
age (P = 0.31), or treatment (P = 0.60), however, there was a treatment by age interaction 
(P < 0.01) for expression of estrus.  For animals administered the 5 + 5 μg treatment, 
expression of estrus was increased (P < 0.01) among heifers compared to cows (84 ± 3% 
vs 70 ± 3%, respectively).  Pregnancy success was influenced by estrus (P < 0.01), 
treatment (P = 0.02), and a treatment by estrus (P < 0.01) interaction, but was not 
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influenced by age (P = 0.91), treatment by age (P = 0.83), or treatment by estrus by age 
(P = 0.94).  Animals that exhibited estrus had increased pregnancy success compared to 
animals that did not exhibit estrus (67 ± 2% vs 41 ± 7% respectively).  Animals 
administered the 5 + 5 µg treatment had increased pregnancy success (P ≤ 0.05; 69 ± 6%) 
compared to animals administered the 0 µg and 10 µg treatments which did not differ (53 
± 6% vs 41 ± 8%, respectively).  Pregnancy success was similar (P > 0.27) between 
animals that did and did not exhibit estrus for animals administered the 0 µg and 5 + 5 µg 
treatments.  For animals administered the 10 µg treatment, conception rates were 
decreased (P < 0.01) among animals that did not exhibit estrus compared to animals that 
exhibited estrus.  This study demonstrated that the 5 + 5 µg treatment of GnRH following 
CIDR removal, when implementing a fixed-time AI protocol, positively influenced 
conception rates. 
 In Chapter 5, beef cows/heifers were synchronized using the CO-Synch protocol 
and artificially inseminated.  On day 16 after insemination animals were transported to a 
local abattoir.  Following slaughter ovaries were collected and all follicles were classified 
as small (< 5 mm), medium (5 to 10 mm), or large (> 10 mm).  Follicles were aspirated to 
collect follicular fluid and granulosa cells.  Follicles were pooled by size within animal (n 
= 23, 16, and 18 for small, medium, and large, respectively).  Follicular fluid 
concentrations of estradiol were determined by radioimmunoassay.  Total cellular RNA 
was extracted from the granulosa cells and RT-PCR was performed to determine relative 
abundance of mRNA for GnRH-I, GnRH-II, and GAPDH.  Data were analyzed using the 
mixed procedure in SAS.  Follicle size influenced concentration of estradiol.  Large 
follicles had increased estradiol (P < 0.0001) compared to small and medium follicles 
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(18,626 ± 2,650 vs 1,270 ± 2,307 and 8,925 ± 2,763 pg/mL, respectively).  There was no 
difference (P = 0.31) in relative abundance of GnRH-I mRNA among small, medium, or 
large follicles (3.8 ± 0.78, 3.40 ± 0.85, and 1.95 ± 0.94; respectively).  Relative 
abundance of GnRH-II mRNA was influenced by follicle size (P < 0.05), with greater 
abundance in small follicles (40.97 ± 9.27) compared to medium (6.32 ± 11; P = 0.02) or 
large (7.85 ± 11.11; P = 0.02) follicles.  However, there was no difference (P = 0.92) in 
relative abundance between medium and large follicles.  When follicles were classified 
by concentration of estradiol, follicles with the lowest 25% of estradiol had decreased 
(LOWE2; P < 0.0001) concentrations of estradiol (434 ± 1,074 pg/mL) compared to the 
middle 50% (MIDE2; 7,029 ± 961 pg/mL) which was decreased (P < 0.0001) compared 
to the greatest 25% (HIGHE2; 46,423 ± 2,025 pg/mL).  LOWE2 had greater (P < 0.01; 
5.37 ± 0.67) abundance of GnRH-I mRNA compared to MIDE2 and HIGHE2 which did 
not differ (1.85 ± 0.55 and 1.23 ± 1.65, respectively).  Relative abundance of GnRH-II 
mRNA was greater (P < 0.01) in LOWE2 (42.33 ± 9.56) compared to MIDE2 (5.98 ± 
8.90).  HIGHE2 was similar (P ≥ 0.12) to the other two groups (8.90 ± 19.12).  Results 
from this study demonstrate a relationship between granulosa cell GnRH-I and II mRNA 
abundance with estradiol concentrations within the follicle, where decreased GnRH-I and 
GnRH-II may be playing a role in increased estradiol production. 
 These three experiments demonstrate GnRH directly impacting estradiol, and/or 
reproductive performance of beef cows and heifers through interval to estrus, expression 
of estrus, and increasing conception rates when used with FTAI protocols.  The 
mechanisms by which GnRH is having its actions remains to be elucidated. 
1 
CHAPTER 2 
LITERATURE REVIEW 
INTRODUCTION 
Estradiol plays a critical role in fertility among cattle, specifically it has been 
reported that preovulatory estradiol regulates reproductive processes that result in 
increased pregnancy success, such as uterine pH (Perry and Perry, 2008), endometrial 
gene expression (Bauersachs et al., 2005) and sperm transport (Larimore et al., 2015) that 
impact embryo development and survival.  Estradiol is also critical within the ovary as it 
is associated with growth, divergence, ovulation, termination, and eventual 
regression/atresia of follicles, atresia may also be attributed to decreased steroidogenesis 
by specific follicles (Bodensteiner et al., 1996b).  Estradiol from the follicle is believed to 
be produced via the two-cell two-gonadotropin hypothesis (Figure 1, Fortune and Quirk, 
1988).  Classically, GnRH from the hypothalamus is transported to gonadotrope cells in 
the anterior pituitary via hypophyseal portal vessels, these gonadotrope cells synthesize 
and release luteinizing hormone (LH) and follicle stimulating hormone (FSH) into the 
systemic circulation that transports them to their endocrine target, the gonads.  
Specifically they act on granulosa and theca cells to regulate processes involved with 
steroidogenesis and folliculogenesis (Schally et al., 1971; Liu and Hsueh, 1986).  
Cows that exhibit estrus prior to FTAI have increased preovulatory concentrations 
of estradiol and greater conception rates compared to those that do not exhibit estrus 
(Perry et al., 2005; Perry et al., 2007; Perry and Perry, 2008; Pereira et al., 2016; 
Richardson et al., 2016).  Previous research indicated that multiple small (5 µg) 
2 
intramuscular injections of GnRH after CIDR removal increased circulating 
concentrations of estradiol (Larimore et al., 2016), likely through the classical pathway.   
 
Figure 1.  Representation of the two-cell, two-gonadotropin theory.  The two cells being 
granulosa and theca cells and the two gonadotropins luteinizing hormone (LH) and 
follicle stimulating hormone (FSH) (Adapted from Erickson, 1978).  
3 
Gonadotropin releasing hormone has been reported to have both inhibitory and 
stimulatory actions on steroidogenesis in the ovary (Sharpe, 1982) and GnRH receptor 
mRNA expression has been characterized in the bovine ovary (Ramakrishnappa et al., 
2003).  However, the specific systemic and local actions of GnRH are not well known.  
This review will delve into literature regarding the bovine estrous cycle, follicle 
development, steroid hormone production, and GnRH actions via the classical 
hypothalamo-pituitary-gonadal axis, as well as, local actions of GnRH at the ovary. 
 
BOVINE ESTROUS CYCLE 
An estrous cycle is characterized by the events that occur between stages of 
sexual receptivity and/or ovulations; the cycle is divided into two phases, the luteal phase 
and the follicular phase, and the average length of the cycle is 21 days (Fortune, 1994; 
Forde et al., 2011).  During the luteal phase (days ~1-17) of the cycle, the dominant 
ovarian structure is the corpus luteum which secretes progesterone, and during the 
follicular phase (days ~18-21), growing follicles secrete estradiol (Senger, 2003).  
Understanding the components of the estrous cycle allows for manipulation and 
intervention of management practices in order to be successful in cattle reproduction. 
 
Luteal Phase 
Ovulation is a traumatic process to the ovarian follicle and results in the rupture of 
blood vessels within the follicular wall.  At this stage the theca cells and any remaining 
granulosa cells luteinize to become either small or large luteal cells to form the corpus 
luteum (CL) (Smith et al., 1994; Howles, 1997; Forde et al., 2011).  The CL is 
4 
responsible for production of progesterone, the major hormone of the luteal phase (Smith 
et al., 1994).  During the luteal phase follicular waves still occur, but there is a disparity 
in estradiol to progesterone concentrations.  The ratio of low estradiol to high 
progesterone concentration exerts negative feedback to the hypothalamus and inhibits 
GnRH release, collectively preventing increased production of estradiol, expression of 
estrus, and ovulation (Adams et al., 1992a; Baratta et al., 1994; Janovick and Conn, 1996; 
Nett et al., 2002). 
 
Follicular Phase 
 Following regression of the CL, progesterone concentrations decline.  In the 
absence of progesterone, the inhibitory feedback to the hypothalamus is removed and 
GnRH is released into the hypophyseal portal vessels resulting in the synthesis and 
release of LH and FSH from gonadotrope cells (Schally et al., 1971; Walters and 
Schallenberger, 1984).  Luteinizing hormone and FSH stimulate growth of the dominant 
follicle and estradiol production.  Elevated concentrations of estradiol, in the absence of 
progesterone, act on the brain to cause behavioral estrus which lasts approximately 12 to 
16 hours (Vailes et al., 1992; Allrich, 1994).  Furthermore, the increased production of 
estradiol from the dominant follicle feeds back positively to the gonadotrope cells to 
increase their responsiveness to GnRH, this allows for frequent LH pulses to occur for a 
period of two to three days that causes a prolonged growing and maintenance of the 
dominant follicle.  This increased responsiveness coupled with increased LH pulse 
frequency, allows for a surge release of LH following a surge of GnRH, resulting in 
ovulation of the dominant follicle, 24 to 30 hours after the onset of estrus (Chenault et al., 
5 
1975; Christenson et al., 1975; Lemon et al., 1975; Adams et al., 1992a; Allrich, 1994; 
Roche, 1996). 
 
Estrus  
Estrus refers to the period of time when the female is sexually receptive to the 
male.  Standing estrus is the visual sign that a female will stand to be mounted by herd 
mates and/or the bull, and typically lasts 12 to 16 hours (Allrich, 1994; Forde et al., 
2011).  Estradiol is the primary signal to the hypothalamus to initiate the expression of 
estrus (Vailes et al., 1992; Diskin and Sreenan, 2000). 
There is a positive relationship between expression of estrus at the time of 
artificial insemination, pregnancy success, and embryo survival until day 30 in beef cattle 
(Vasconcelos et al., 1999; Perry et al., 2005; Perry et al., 2007; Jinks et al., 2013; Pereira 
et al., 2016; Richardson et al., 2016).  Variations in interval to estrus and pregnancy 
success in FTAI protocols have been hindrances to the successful use of protocols to 
synchronize estrus (Roche and Boland, 1991; Bo et al., 1994).  Investigation in 
implementing tools (i.e. hormones) to manipulate the estrous cycle in a way to enhance 
expression of estrus presents an imperative area of research. 
There are many factors that impact the expression of estrus.  Specifically, 
increased circulating cortisol has been shown to delay and/or block the preovulatory LH 
surge and expression of estrus (reviewed by Stevenson, 2001).  Another factor to 
consider when managing a cow/calf beef herd would be postpartum anestrous, as it is 
compounded by other factors such as body condition score at calving, nutrition, calf 
presence, and previous dystocia (Short et al., 1990; Stagg et al., 1998).  Postpartum beef 
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cows or first-calf heifers are dealing with decreased GnRH-induced LH release (Roche et 
al., 1992), which is inhibitory to estrus (Vailes et al., 1992).  Furthermore these 
postpartum cows are raising a calf, and in instances where the animal is in a negative 
plane of nutrition, reproductive traits are lower in priority ranking in the nutrient 
partitioning hierarchy (Short and Adams, 1988); in discussing nutrient availability and 
partitioning, special consideration must be made for first calf heifers that are still growing 
themselves while raising their new calf.  All of the aforementioned conditions pose 
hindrances in re-initiating cyclicity and successful expression of estrus. 
 
Fertilization 
 Increased estradiol concentrations in the absences of progesterone, positively 
feedback to induce the surge release of LH and the subsequent ovulatory cascade 
(Allrich, 1994), resulting in an oocyte being released into the oviduct (Senger, 2003).  
Approximately 12 hours after the initiation of standing estrus is the optimal time for 
spermatozoa to be introduced into the tract via natural service or artificial insemination 
(Chenault et al., 1975; Christenson et al., 1975; Lemon et al., 1975; Adams et al., 1992a; 
Allrich, 1994; Roche, 1996).  Once in the female tract, spermatozoa begin their journey 
to the oviduct, during this time the sperm are undergoing a process known as 
capacitation, which results in the removal of seminal plasma proteins from the sperm 
head to allow for binding to the oocyte, this process is supported by secretions of the 
female reproductive tract, containing Na
+
, K
+
, and Ca
2+ 
(Fraser, 1992, 1998).  Next, the 
spermatozoa free of seminal plasma proteins and cholesterol make contact with the zona 
pellucida and must undergo the acrosome reaction in order to fertilize the oocyte 
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(Yanagimachi, 1988).  The acrosome reaction commences when the spermatozoa makes 
contact with the zona pellucida of the oocyte (Ward and Kopf, 1993). The zona pellucida 
consists of three glycoproteins (ZP1, ZP2, and ZP3) (Wassarman, 1988; Wassarman and 
Mortillo, 1991).  Once the sperm has bound, and fertilization takes place, the zona block 
occurs which prevents additional sperm from penetrating the zona pellucida (Braden et 
al., 1954). 
 In order to achieve successful ovulation of oocytes, that can later be fertilized and 
develop into offspring there are strict requirements.  Ovarian steroidogenesis and 
folliculogenesis are the necessary precursors to successful reproduction.  Therefore, the 
purpose of the following sections is to review literature regarding follicular growth, and 
steroid hormone production, specifically estradiol and progesterone. 
 
FOLLICULOGENESIS 
 Follicular development in cattle occurs in wave like patterns, and there are 
typically two to three waves per estrous cycle (Rajakoski, 1960; Ireland and Roche, 1983; 
Roche and Boland, 1991; Fortune, 1994; Forde et al., 2011).  Evidence for this style of 
growth has been reported in calves as early as two weeks of age (Evans et al., 1994; 
Ginther et al., 1996).  The initiation of follicular waves is characterized by a small cohort 
of follicles beginning to grow under the influence of increasing concentrations of FSH 
(Adams et al., 1992b; Evans et al., 1994).  During these follicular waves a dominant 
follicle emerges.  Dominant follicles then have one of two fates, atresia or ovulation 
(Bodensteiner et al., 1996b; Quirk et al., 2004).  This section will review the process of 
folliculogenesis in more detail. 
8 
Follicle Populations/Classification 
 Follicles contained within the ovary can be classified into one of two classes; 
preantral follicles: primordial, primary, and secondary, and antral follicles: tertiary.  The 
dynamics of preantral-secondary and antral follicles involve four processes: recruitment, 
selection, dominance, and ovulation or atresia (Fortune, 1994; Bodensteiner et al., 1996a; 
Bodensteiner et al., 1996b; Howles, 1997; Senger, 2003).  Cattle are born with 
approximately 133,000 total primordial (non-growing) follicles, whose numbers remain 
fairly consistent until four years of age when they begin to decrease until there are few to 
none remaining at approximately fifteen to twenty years of age (Erickson, 1966).  These 
primordial follicles are the pool from which cohorts of growing follicles are derived.  
Growing follicles (preantral and antral) rapidly increase in number from one month of 
age until almost four months of age, then continue to increase in number gradually and 
then remain constant up until puberty, at this time growing follicle numbers begin to 
decrease in a fashion similar to what is observed among primordial follicles (Erickson, 
1966).  A transient rise in FSH stimulates each wave of recruitment (Adams et al., 1992b; 
Sunderland et al., 1994).  There are three proposed models by which a dominant follicle 
is selected for continued growth and ovulation or atresia.  The three models are, 1) LH 
receptor expression in granulosa cells resulting in a shift from FSH to LH dependency 
(Xu et al., 1995; Bao et al., 1997), 2) Increased concentrations of estradiol preceding the 
gonadotropin dependence shift from FSH to LH (Evans and Fortune, 1997), and 3) 
Increased availability of insulin-like growth factors as a result of degradation of IGF-BP 
acting synergistically with gonadotropins to stimulate follicular cell growth and 
differentiation (Giudice, 1992; Spicer and Echternkamp, 1995).  The single dominant 
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follicle within the cohort of antral follicles, can more effectively bind gonadotropins, has 
increased estradiol to a low progesterone ratio and is the one that continues to grow to 
preovulatory status (Ireland and Roche, 1983; Quirk et al., 2004).   
 
Antral Follicles 
Ovarian follicles are the main functional unit of the ovary.  They are responsible 
for producing steroid hormones, ovulating oocytes, and luteinizing into corpora lutea to 
assist in the maintenance of pregnancy.  Antral/tertiary follicles are composed of two 
outer layers of theca cells, the theca interna and the theca externa.  The theca cell layers 
are supplied by a vasculature network and separated from the other components of the 
follicle by a basement membrane.  Theca interna cells play a role in steroid production 
and contain LH receptors, while the theca externa provide structural support for the 
follicle.  Within the basement membrane are the avascular granulosa cells which also 
play a role in steroid production and have FSH receptors (Senger, 2003; Rodgers and 
Irving-Rodgers, 2010).  Preantral and early antral bovine follicles that are between 2 and 
4 mm in diameter are believed to be gonadotropin-independent, while the growth of 
bovine antral follicles greater than 4 mm in diameter is considered to be gonadotropin 
dependent (Bao and Garverick, 1998; Orisaka et al., 2009).  The central cavity (antrum) 
of the follicle is filled with follicular fluid, which is derived from secretions of the 
surrounding cells as well as a result of fluid movement from the extra-follicular 
space/vasculature (Rodgers and Irving-Rodgers, 2010).  A specialized group of granulosa 
cells exists that crowns the oocyte, this group of cells is termed the cumulus oophorus 
(Senger, 2003; Rodgers and Irving-Rodgers, 2010).  The follicular fluid is kept separate 
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from the rest of the body/circulation, and maintains an environment rich in steroids, 
proteins, and growth factors conducive to follicular and oocyte maturation (Smith et al., 
1994; Roche, 1996; Howles, 1997).  Antral follicles vary by size and are often classified 
as either small (less than 5 mm), medium (5 to 10 mm) or large (greater than 10 mm; 
(Matton et al., 1981). 
 
STEROIDOGENESIS 
 Steroid production is reliant on the transfer of cholesterol into the inner 
mitochondrial membrane via steroidogenic acute regulatory protein (StAR) that has been 
localized to the theca interna.  Both theca and granulosa cells contain cytochrome P450 
side chain cleavage enzyme (P450scc) which is needed for the conversion of cholesterol 
to pregnenolone, pregnenolone is then converted to 17 hydroxy-progesterone and then 
androstenedione via 17 α-hydroxylase cytochrome P450 enzyme (P45017α), 
androstendione is converted to testosterone via 3β-hydroxysteroid dehydrogenase enzyme 
(3βHSD) (Bao et al., 1997).  Testosterone within the theca cells can then cross the 
basement membrane and enter the granulosa cells.  Granulosa cells bind FSH and convert 
testosterone into estradiol by working in concert with the enzyme cytochrome P450 
aromatase (P450arom) (Liu and Hsueh, 1986; Fortune and Quirk, 1988; Bodensteiner et 
al., 1996b; Bao and Garverick, 1998).  Maximal steroid hormone concentrations are 
observed in the follicular fluid as a result of increased expression of mRNA for 
gonadotropin receptors, steroidogenic enzymes and StAR (Bao and Garverick, 1998). 
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Estradiol 
Cytochrome P450 scc and cytochrome P450 aromatase enzymes are responsible 
for the steroidogenic pathway leading to the production of estradiol, and have been 
detected in granulosa cells as early as recruitment (Figure 2; Bao and Garverick, 1998).  
However, among preantral and antral follicles less than 4 mm in diameter, granulosa cell 
expression of cytochrome P450 aromatase was undetectable, this suggesting that these 
follicles are unable to convert testosterone to estradiol within the granulosa cells and 
giving rise to the conclusion that follicles less than 5 mm in diameter are estrogen-
inactive (Ireland and Roche, 1983; Bao and Garverick, 1998).  Estradiol in bovine 
follicles has a positive feedback effect on its own production by inhibiting progesterone 
secretion by granulosa cells (Fortune and Quirk, 1988), and by positively feeding back to 
the hypothalamus to stimulate GnRH to induce LH release from the anterior pituitary 
(Baratta et al., 1994) by increasing the number of GnRH receptors at the level of the 
anterior pituitary (Gregg et al., 1991).  Estradiol and FSH in increasing concentrations 
induced increased LH receptor binding sites on granulosa cells in rats (Bodensteiner et 
al., 1996b).  Estradiol may also be modulating its own synthesis, as an in vivo 
pretreatment of Estradiol 17β was shown to inhibit 17α-hydroxylation in vitro by rat 
theca interstitial cells (Magoffin and Erickson, 1981) thus preventing the conversion of 
progestins to androgens, leaving insufficient androgen substrate that subsequently inhibits 
estrogen synthesis (Liu and Hsueh, 1986).   
Culturing of human granulosa-luteal cells with estradiol resulted in a decrease in 
GnRH and GnRH-R mRNA (Nathwani et al., 2000; Kang et al., 2001a).  Specifically at 
concentrations as low as 1 nM of estradiol, GnRH mRNA abundance was reduced by 
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45% compared to control, and at an estradiol concentration of 100 nM a 70% decrease in 
GnRH mRNA was observed relative to the control.  Similar results were observed for 
GnRH-R mRNA with a 40% and 65% decrease in GnRH-R mRNA for the 1 nM and 100 
nM concentration of estradiol, respectively (Nathwani et al., 2000). 
Furthermore there was a positive relationship between follicle size and peak 
estradiol concentration among cows that exhibited estrus (Perry et al., 2014).  Previous 
research has also reported a relationship with follicles size, circulating concentrations of 
estradiol, and pregnancy success to AI among beef cattle (Perry et al., 2005).  When 
employing synchronization protocols for the use of artificial insemination, cattle are 
sometimes forced to ovulate smaller follicles, with the administration of GnRH, in these 
instances, animals experience decreased pregnancy success due to decreased estradiol 
production of that smaller follicle (Perry et al., 2005). 
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Figure 2.  Ovarian biosynthesis of Estradiol-17β.  The steroidogenic pathway with its 
steroid hormone intermediates and respective enzymes are illustrated.  
Dehydroepiandrosterone (DHEA), Cytochrome P450 side chain cleavage (P450scc), 3β-
hydroxysteroid dehydrogenase (3βHSD), 17α-hydroxylase cytochrome P450 (P45017α), 
17β-hydroxysteroid dehydrogenase (17βHSD), and cytochrome P450 aromatase 
(P450arom) (Adapted from Hadley and Levine, 2007). 
 
 
 
 
 
 
3βHSD 
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Progesterone 
 During the mid-luteal phase of the estrous cycle endogenous progesterone 
concentrations are increased due to production by the CL.  As mentioned above, in 
employing synchronization protocols when an animal is forced to ovulate smaller 
follicles, estradiol concentrations peak at a lower concentration and those smaller follicles 
have fewer granulosa and theca cells, which luteinize to form an inferior CL. Lishman 
and Inskeep (1991) summarized that inferior CL function can arise from a variety of 
situations 1) Deficiencies in maturation of the preovulatory follicle and/or in the 
ovulatory stimulus, 2) Inadequate support of the CL once it has formed, or 3) Premature 
activation of the luteolytic process.  These inferior CLs lead to decreased pregnancy 
success as well (Perry et al., 2005).  
 During the luteal phase, follicular waves still occur, but due to high progesterone 
concentrations inhibiting surge releases of GnRH, LH, and FSH, the dominant follicles 
do not ovulate, but becomes atretic (Adams et al., 1992a; Baratta et al., 1994; Janovick 
and Conn, 1996; Nett et al., 2002).  When Adams et al. (1992a) injected early-luteal 
phase, nulliparous Holstein heifers with varying doses of progesterone, they found that 
animals injected with higher doses of progesterone had hastened follicular wave 
emergence and suppression of growth of the dominant follicle.  Thus demonstrating the 
negative feedback of progesterone on LH pulsatile secretion.  However, FSH was not 
suppressed, resulting in hastened emergence of subsequent anovulatory follicular waves. 
Prolongation of the growing phase of the ovulatory follicle was observed with low 
and declining concentrations of progesterone after the cessation of treatment (Adams et 
al., 1992a), this added to the hypothesis that increased LH pulse frequency resulting from 
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low circulating progesterone is responsible for promoting continued growth and 
maintenance of the dominant follicle (Adams et al., 1992a).  In conclusion, in the 
presence of progesterone and decreased estradiol, follicular waves still occur in cows but 
ovulation does not take place. 
 
GONADOTROPIN RELEASING HORMONE 
Gonadotropin releasing hormone is a decapeptide which was originally isolated 
from 150,000 porcine hypothalami by the work of three scientists, Schally, Guillemin, 
and Yalow, who won the Nobel Prize in 1977.  Since its discovery, 24 different forms of 
GnRH have been identified (Figure 3), among those, three distinct isoforms have been 
characterized (GnRH-I, GnRH-II, and GnRH-III).  Only GnRH-I and GnRH-II have been 
found in mammals, specifically GnRH-I is thought to work predominantly through the 
classical hypothalamo-pituitary-gonadal axis while GnRH-II actions have been reported 
predominantly in extra-pituitary sites (Millar, 2005), making it of special interest to 
researchers in the field of reproductive physiology.  Gonadotropin releasing hormone-II, 
specifically was discovered from 10,000 chicken hypothalami, and was 30% as potent as 
mammalian GnRH (GnRH-I) in its ability to cause the release of gonadotrophs in a 
bioassay (rat anterior pituitary cells; (Miyamoto et al., 1984).  The carboxy and amine 
terminal residues of the GnRH peptide are highly conserved across species with amino 
acids 5-8 being more variable.  Amino acid 8 of the GnRH peptide is thought to be the 
most variable amino acid and allows for ligand-receptor specificity (Millar, 2005).   
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Figure 3.  Primary amino acid sequence of GnRH forms named for the species in which 
they were discovered.  The boxed regions show conserved carboxy and amine terminal 
residues.  The non-conserved amino acids are thought to be either unimportant or 
responsible for ligand-selectivity of different GnRH receptors (Adapted from Millar, 
2005). 
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Gonadotropin releasing hormone, or longer lasting GnRH analogs are used 
extensively for reproductive management in cattle.  Specifically, GnRH can be used to 
induce postpartum ovulations, reversibly suppress ovarian activity, and more commonly 
can be used to synchronize estrus and ovulation (D'Occhio and Aspden, 1999).  
Gonadotropin releasing hormone injections (100 μg i.m.) administered during 
synchronization protocols can induce ovulation of inferior/smaller follicles, resulting in 
decreased estradiol concentrations.  Therefore investigation into methods to increase 
estradiol production in synchronization protocols presents an important area of research 
(Jinks et al. 2013; Perry et al., 2014). 
When injecting animals with GnRH it is difficult to distinguish whether changes 
are a result of local actions of GnRH or if they are secondary to the pituitary release of 
LH and FSH.  In the following sections the local actions of GnRH in mammalian species 
will be discussed further, and special considerations for employing GnRH in cattle 
reproductive management systems will be discussed. 
 
Localization of GnRH 
Gonadotropin releasing hormone, like other hypothalamic peptides, has extra-
pituitary actions (Ortmann and Diedrich, 1999; Millar, 2005; Ramakrishnappa et al., 
2005).  Considerable research has been focused on actions of GnRH at the ovarian level.  
Expression of GnRH in the ovary was first characterized in rats via ligand binding 
(Clayton et al., 1979; Jones et al., 1980; Reeves et al., 1980).  Expression was next 
localized to primary, secondary, and tertiary follicles of rats (Clayton et al., 1979; 
Whitelaw et al., 1995).  Both GnRH-I and GnRH-II have been demonstrated in the 
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human ovary via RT-PCR and southern blot analysis (Peng et al., 1994; Kang et al., 
2000; Choi et al., 2001). 
Expression of GnRH mRNA has also been characterized in granulosa cells of 
small, medium, and large bovine antral follicles and luteal tissue (Ramakrishnappa et al., 
2003), and in human and rat granulosa and luteal cells (Minaretzis et al., 1995; Olofsson 
et al., 1995; Kang et al., 2001b).  A GnRH-like molecule was first identified in bovine 
follicles, and suppressed the LH-stimulated accumulation of cAMP in a dose dependent 
manner (Aten et al., 1987).  Furthermore this GnRH-like molecule was in greatest 
concentrations in bovine granulosa cells (Ireland et al., 1988). 
 
GnRH Actions on Folliculogenesis 
Gonadotropin releasing hormone antibody infusion into prepubertal porcine 
ovarian tissue resulted in a decreased number of follicles greater than 0.5 mm in 
diameter, and increased incidence of atresia in follicles with greater than 4 layers of 
granulosa cells.  However, there were no reported differences in number of follicles less 
than 0.5 mm in diameter nor were circulating concentrations of estradiol, LH, and FSH 
affected, likely due to the fact that only one ovary was infused (Patton et al., 1991); thus 
providing evidence of direct action of GnRH as follicles at this stage are gonadotropin 
independent (Orisaka et al., 2009).  Other methods of GnRH administration may have 
impacted folliculogenesis either through direct actions on the ovary or through regulation 
of LH release.  When small doses (5 µg and 10 µg) of GnRH agonist were injected (i.m.) 
into heifers twice daily for three weeks, pulsatile secretion of LH was suppressed and 
development of follicles beyond 9 mm was blocked, the combined effects prevented 
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increased estradiol production to allow for the preovulatory LH surge and ovulation 
(Gong et al., 1995).  Upon cessation of the treatment dominant follicles reached ovulatory 
size and ovulated (Gong et al., 1995).  Deslorelin (a GnRH analog) implants of 700 µg 
slightly delayed the emergence of the third dominant follicle in non-lactating Holstein 
cows implanted 4 days after ovulation, while Deslorelin implants of 2100 µg drastically 
delayed the selection of the third dominant follicle, and extended the estrous cycle 
(Rajamahendran et al., 1998).  The number of medium antral follicles was reduced in the 
700 µg and 2100 µg Deslorelin implanted groups, and overall the 700 µg Deslorelin 
group had the fewest large antral follicles compared to control cows between days 13 and 
19 following ovulation (Rajamahendran et al., 1998).  All of the aforementioned studies 
reported inhibitory actions of GnRH on follicular growth. 
When nulliparous Holstein heifers were treated with GnRH approximately 32 
hours before ovulation (100 µg i.m., Cystorelin) variability in interval from GnRH 
treatment to ovulation was reduced, ovulation occurred at 32 hours in GnRH treated 
heifers versus 48 to 56 hours for the control group; GnRH treatment also  allowed for 
quicker attainment of: maximal FSH concentrations, emergence of a dominant follicle, 
and ovulation of the dominant follicle in the subsequent wave (Bodensteiner et al., 
1996a).  In the same study, GnRH treatment increased the number of follicles greater 
than 5 mm per wave by 53%, all of these showing a stimulatory effect of GnRH on 
follicular growth (Bodensteiner et al., 1996a). 
In regards to one of the fates of growing follicles, atresia, GnRH has been 
reported to have direct effects on apoptosis in the ovary.  The initiation of apoptosis in 
granulosa cells is one of the earlier signs of atresia, and is a process in which unwanted 
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cells can be selectively eliminated (Tilly and Hsueh, 1993; Yuan and Giudice, 1997).  
Furthermore research exists that supports the direct effects of GnRH in regulating 
follicular atresia and induction of cellular apoptosis (Hsueh et al., 1984; Piquette et al., 
1991; Billig et al., 1994; Whitelaw et al., 1995; Motomura, 1998; Sridaran et al., 1998).  
High expression of GnRH-R mRNA has been found in atretic follicles of rats during the 
follicular phase (Whitelaw et al., 1995) and in vitro studies with GnRH inhibited DNA 
synthesis and stimulated the induction of apoptosis, with the actions of GnRH being 
confined to the rat granulosa cells (Billig et al., 1994; Saragueta et al., 1997).  This 
stimulatory effect of GnRH in inducing apoptosis has also been observed in porcine and 
human granulosa cells (Zhao et al., 2000). 
 
GnRH Actions on Steroidogenesis 
Gonadotropin releasing hormone has been reported to have both stimulatory and 
inhibitory actions on ovarian function and subsequently steroidogenesis (Sharpe, 1982; 
Janssens et al., 2000).  In cultured rat granulosa cells the use of a GnRH analog inhibited 
ovarian growth by blocking estradiol secretion, by inhibiting the induction of LH 
receptors via FSH and the aromatase enzyme (Hsueh et al., 1980).  Gonadotropin 
releasing hormone has also been reported to decrease expression of granulosa FSH and 
LH receptors (Piquette et al., 1991; Tilly et al., 1992), and luteal cytochrome P450 scc 
(P450 scc) and 3βHSD (Sridaran et al., 1999a; Sridaran et al., 1999b) in both in vitro and 
in vivo experiments using rats.  In a study by Larimore et al. (2016) beef cows that did 
not exhibit estrus prior to fixed-time AI treated with intramuscular injections of GnRH (5 
µg), every eight hours from the time of prostaglandin administration (hour 0) to 33 hours, 
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had decreased abundance of mRNA for 3βHSD and P450 scc in granulosa cells, 
indicating decreased function of the steroidogenic pathway.  Administration of GnRH 
(100 µg i.m.) results in an LH surge, and following an LH surge, aromatase activity is 
down regulated resulting in decreased circulatory and follicular estradiol concentrations 
(Komar et al., 2001). 
Studies on human ovaries indicated that GnRH-II also inhibited LH and FSH 
receptor expression (Kang et al., 2001b).  Gonadotropin releasing hormone agonists 
added in vitro have a dose-dependent stimulatory effects on aromatase activity, the 
enzyme responsible for the conversion of androgens to estrogens, and progesterone 
production in monkey granulosa cells (Janssens et al., 2000).  When a GnRH agonist was 
added to cultured bovine granulosa cells at a concentration of 200 ng/mL it had a 
stimulatory effect on estradiol production, however, at concentrations of 500 ng/mL and 
1000 ng/mL it had an inhibitory effect on estradiol production (Ramakrishnappa et al., 
2005).  In in vitro human granulosa-luteal cells, GnRH-I mRNA abundance was down 
regulated by 17β-estradiol (Nathwani et al., 2000; Kang et al., 2001a).  Gonadotropin 
releasing hormone-I suppressed expression of estrogen receptor α and β via a PKC-
dependent pathway in human granulosa cells, thus providing a way for GnRH to 
counteract the inhibitory actions of estradiol on its own expression (Chiang et al., 2000).  
The aforementioned studies show the various mechanism by which GnRH and estradiol 
can regulate one another via the classical pathway- secondary to gonadotropin sensitivity 
or locally, and the resulting stimulatory and inhibitory actions that can be observed. 
Continuous infusion of low doses of GnRH stimulate gonadotropin release 
without pituitary desensitization and down-regulation of GnRH receptors ([s.c. 20 µg/h] 
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(Lamming and McLeod, 1988); [i.v.2.5 µg/h] (Jagger et al., 1987).  Pulsatile secretion of 
LH has also been shown to be blocked in studies where cattle are treated with GnRH 
analogs or agonists, as a result of pituitary desensitization and receptor down regulation 
(Vizcarra et al., 1997).  Treatment of non-lactating Holstein cows with a GnRH (8 µg) 
intramuscular injection and Deslorelin (a GnRH analog) implants (700 µg and 2100 µg) 
induced a rapid LH surge (Rajamahendran et al., 1998).  In the same study by 
Rajamahendran et al. (1998), greater progesterone concentrations were observed from 
days 14 to 18 after ovulation in the 700 µg and 2100 µg Deslorelin implant groups 
compared to controls, thus showing a stimulatory effect of GnRH on progesterone 
production.  In another study a GnRH agonist (100 ng) had an inhibitory effect on 
progesterone secretion when added to bovine luteal cell cultures thus providing evidence 
of direct actions of GnRH on luteal cells (Milvae et al., 1984).  Furthermore, in a study 
by Harwood et al. (1980), hCG stimulated progesterone production by collagenase-
dispersed rat luteal cells via LH receptor binding was inhibited by a GnRH agonist, this 
inhibition was overcome as greater concentrations of hCG were used.  In the same study, 
GnRH agonist shifted the dose response curve by an order of magnitude to the right 
without changing the maximal progesterone production of epinephrine stimulated 
collagenase-dispersed rat luteal cells (Harwood et al., 1980).  From these studies it is 
clear that GnRH has both stimulatory and inhibitory actions on progesterone production. 
In a study by Peng et al. (1994) using human granulosa-luteal cells, GnRH 
increased GnRH mRNA abundance at low doses, but had no effect or a slight inhibitory 
effect on GnRH gene expression at higher doses.  Preovulatory rat granulosa cell GnRH 
gene expression was up-regulated when GnRH (1.18 μg/mL) was added to the culture 
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medium (Olofsson et al., 1995).  This relationship was also reported for GnRH-II, where 
GnRH-II differentially regulated its own expression; treatment with GnRH-II, resulted in 
significant down-regulation of both GnRH-I and GnRH receptor mRNA levels in human 
granulosa-luteal cells (Kang et al., 2001b).  From these studies, it is evident that GnRH-I 
and GnRH-II are modulating their own release. 
The aforementioned actions of GnRH on steroidogenesis provide in vitro and in 
vivo evidence of how GnRH exerts direct stimulatory and inhibitory effects either on its 
own or in combination with other factors.  Furthermore, the actions of GnRH have 
contradicting actions in different species, or even when employing different research 
methods, which, can make the prospect of studying the effects of GnRH challenging. 
 
GnRH Inferred-Actions on Estrus 
A 5 µg dose of GnRH elicits an LH pulse similar to a physiological pulse (Ginther 
et al., 1996), and increased LH pulsatility increased estradiol concentrations (Fortune et 
al., 2001).  Beef cows injected with GnRH (5 µg) intramuscularly every 8 hours from the 
time of prostaglandin injection (hour 0) to 33 hours after, had elevated estradiol 
concentrations at hours 7, 8, and 16 (Larimore et al., 2016), this was thought to occur via 
GnRH inducing increased LH pulsatility.  Heifers treated with a GnRH agonist 24 hours 
after prostaglandin injection had increased diameter of the dominant follicle (Pursley et 
al., 1997; Taponen et al., 1999; Taponen et al., 2000), and this was associated with 
increased plasma concentrations of estradiol (Bergfeld et al., 1996; Maclellan et al., 1997; 
Dufour et al., 1999).  As mentioned above, estradiol is the primary signal to the 
hypothalamus to initiate the expression of estrus (Vailes et al., 1992; Diskin and Sreenan, 
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2000).  Therefore, one can infer that GnRH may positively contribute to the expression of 
estrus, via gonadotropin stimulation.  Furthermore, a meta-analysis conducted using over 
10,000 beef cattle from 22 studies reported that animals that exhibit estrus prior to fixed-
time artificial insemination had greater conception rates compared to animals that did not 
exhibit estrus prior to insemination (Richardson et al., 2016).  Therefore, the role of 
GnRH in inducing favorable effects (increased estradiol concentrations) when subjecting 
cattle to fixed-time artificial insemination programs presents an essential interaction to be 
investigated, and will be discussed further in the subsequent chapters. 
 
GnRH Actions on Fertilization 
 Gonadotropin releasing hormone impacts fertilization both directly and indirectly.  
Indirect actions of GnRH that positively impact fertilization do so by changing 
expression of estrogen receptors at the level of the endometrium (Singh et al., 2009).  
Specifically, gonadotropin releasing hormone increased expression of ERα in cultured 
luteal phase bovine endometrium, suggesting the role it might be playing in inducing 
endometrial responsiveness to estradiol and the associated effects: uterine receptivity, 
uterine pH, implantation, and maintenance of pregnancy (Singh et al., 2009).   
Gonadotropin releasing hormone has been identified in the ovary of many species 
(Aten et al., 1987; Oikawa et al., 1990), and more specifically rat follicular fluid (Ying et 
al., 1981), bovine granulosa cells (Ireland et al., 1988), and the bovine uterus and oviduct 
(Singh et al., 2008).  Knowing this, it becomes evident that during natural service or 
artificial insemination, those spermatozoa are coming into contact with GnRH within the 
female reproductive tract, and that GnRH in turn has the opportunity to directly impact 
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fertilization.  Specifically, in humans, GnRH and its analogs were shown to increase 
binding of spermatozoa to the zona pellucida (Morales and Llanos, 1996).  Additionally, 
GnRH agonists were also reported to increase the cleavage rates of bovine oocytes in 
vitro (Funston and Seidel, 1995).  Overall, GnRH seems to play a vital role in the 
processes involved with successful fertilization.  
 
GnRH Receptors 
As there are three distinct isoforms of GnRH, the existence of distinct receptor 
types is expected (Troskie et al., 1998), and presents as a formative area of research.  
Gonadotropin releasing hormone-I receptor is structurally and functionally different from 
the GnRH-II receptor (Millar, 2005; Ramakrishnappa et al., 2005).  Receptors for both 
GnRH I and II are expressed in the gonadotrope cells of the anterior pituitary.  The 
presence of GnRH-II receptor within the brain is thought to mediate sexual behavior, and 
the presence of GnRH-II receptor within reproductive tissues is indicative of the local 
role of GnRH-II (reviewed by Ramakrishnappa et al., 2005).  Specifically, researchers 
have found that GnRH-II is about 30% as potent as mammalian GnRH (GnRH-I) in its 
ability to cause the release of gonadotropins in a bioassay of rat anterior pituitary cells 
(Miyamoto et al., 1984).  Factors exist that are known to alter the expression of GnRH 
receptors and subsequently the number of GnRH receptors within the anterior pituitary, 
these include gonadal steroids, estradiol and progesterone, inhibin, activin, and GnRH 
itself in rats, sheep, and cattle (Gregg et al., 1991; Braden and Conn, 1992; Turzillo and 
Nett, 1999).  In humans, GnRH was reported to up-regulate GnRH receptor gene 
expression (Peng et al., 1994). 
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Expression of GnRH receptors is lowest in the anterior pituitary during the luteal 
phase, when progesterone concentrations are increased, in sheep (Crowder and Nett, 
1984; Brooks and McNeilly, 1994; Turzillo et al., 1998).  Furthermore progesterone 
decreased the number of ovine pituitary GnRH receptors, while in the same study inhibin 
increased GnRH receptors (Laws et al., 1990).  Inhibin and estradiol added in culture to 
ovine pituitary cells increased GnRH receptor numbers, while activin decreased GnRH 
receptor numbers (Gregg et al., 1991).  Expression of GnRH receptor has been 
characterized in bovine granulosa cells, and was increased in granulosa cells of small 
follicles compared to medium and large follicles (Ramakrishnappa et al., 2005).  
Gonadotropin releasing hormone receptor has also been identified in human granulosa-
luteal cells (Peng et al., 1994). 
 
Special considerations in studying effects of GnRH 
 It is hard to distinguish direct gonadal actions from indirect actions of GnRH; 
those that are in response to the GnRH peptide itself versus those mediated by the 
hypothalamus that result in the synthesis and release of LH and FSH.  Gonadotropin 
releasing hormone is diluted 1:500 from the time it travels from the hypophyseal portal 
vessels out to the systemic jugular vein (Nett et al., 1974).  Furthermore, circulating 
levels of GnRH are known to be as low as 10 pg/mL in rats, rabbits, and rhesus monkeys 
(Eskay et al., 1977; Neill et al., 1977; Tsou et al., 1977).  Therefore, experimental 
modeling becomes crucial, and Janssens et al. (2000) listed factors that may be involved 
in some of the contradicting results that can be observed when studying GnRH, including 
(1) The type and dose of GnRH analog used, (2) The different administration routes, (3) 
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Ovarian status at the time of exposure, (4) The ovarian cell types used in in vitro studies, 
and (5) Variation in GnRH receptor types and abundance which is dependent on species 
and/or ovarian status.   
The effects of GnRH have been studied in a variety of ways; researchers have 
infused GnRH directly into ovarian tissue (Patton et al., 1991), studied the effects of 
GnRH in cultures (Sharpe, 1982; Milvae et al., 1984; Funston and Seidel, 1995), utilized 
hypophysectomized animals see review by Sharpe (1982), and GnRH has been injected 
systemically or implanted (Gong et al., 1995; Rajamahendran et al., 1998; Larimore et 
al., 2016).  In implementing all of these methods to study GnRH, researchers are able to 
delineate multiple diverse actions of GnRH and ultimately add imperative information to 
the goal of understanding the mechanisms by which GnRH works systemically and 
locally to impact reproductive processes.  That being said, there is still much to gain in 
exploring the actions of GnRH when introduced systemically in non-hypophysectomized 
animal models.  
 
CONCLUSIONS 
 It is clear that there is still much to gain in improving cattle reproductive 
efficiency and how we implement reproductive management tools.  What is causing the 
variation we observe in interval to estrus and pregnancy success with our FTAI 
protocols?  Why do some growing follicles produce more estradiol than other follicles?  
How is GnRH having its stimulatory and inhibitory effects within the ovary?  Is 
systemically administered GnRH working solely through gonadotrope cells in the 
anterior pituitary, or does it have the ability to act directly on ovarian follicles?  The 
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following chapters will present field trials in which small doses of GnRH were 
systemically administered at the time of CIDR removal during a synchronization protocol 
and the reported effects on reproductive parameters, as well as the abundance of GnRH-I 
and GnRH-II mRNA in bovine granulosa cells and how that abundance related to 
follicular fluid estradiol concentrations of bovine antral follicles. 
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CHAPTER 3 
INFLUENCE OF GnRH SUPPLEMENTATION AT CIDR REMOVAL ON 
EXPRESSION OF ESTRUS AND INTERVAL TO ESTRUS IN BEEF CATTLE 
ABSTRACT 
Previous research has indicated that multiple small doses of GnRH after CIDR 
removal increased circulating concentrations of estradiol.  Thus our objective was to 
determine if a single small dose of GnRH (5 μg or 10 μg) at CIDR removal would impact 
expression of estrus and/or interval to estrus.  Beef cows and heifers (n = 1620) were 
synchronized using the 7-day CIDR protocol, and randomly assigned to one of three 
treatments (0, 5, or 10 µg of a GnRH analog at CIDR removal).  Animals were visually 
observed for estrus and inseminated following detection in estrus.  Interval to estrus was 
calculated for each animal that exhibited estrus (INTERVAL 1).  Animals that did not 
exhibit estrus were given 100 μg of GnRH at the time of AI and their interval to estrus 
was designated at 120 h.  INTERVAL 2 refers to the interval when animals that did not 
exhibit estrus were included in the analysis.  Interval to estrus was analyzed using the 
MIXED procedure of SAS.  Expression of estrus and pregnancy success were analyzed 
using the GLIMMIX procedure of SAS with treatment and age as independent variables 
and herd as a random effect.  There was an effect of age (P < 0.01) and a treatment by 
age interaction (P = 0.05) on INTERVAL 1.  Heifers had a shorter interval to estrus than 
cows (50 h vs 54 h, respectively).  Furthermore, heifers given 5 μg of GnRH tended to 
have a shorter interval to estrus (P = 0.07; 47 ± 1.4 h) compared to 0 μg (50 ± 1.5 h) and 
did have a shorter interval compared to 10 μg (P < 0.01; 52 ± 1.5 h).  There were no 
differences between treatments in interval to estrus among cows (P > 0.34).  When 
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animals that did not exhibit estrus were included in the analysis at 120 h there was no 
treatment by age interaction (P = 0.49).  This is likely due to the fact that treatment (P < 
0.01), but not age (P = 0.96) or treatment by age (P = 0.74) influenced expression of 
estrus, with 5 μg tending to have more animals in estrus (P = 0.10; 79 ± 4%) compared to 
0 μg (74 ± 5%), and 10 μg having fewer animals in estrus compared to either other 
treatment (P < 0.04; 68 ± 6%).  Estrus (P < 0.01) and age (P < 0.01) influenced 
pregnancy success with heifers having greater pregnancy success compared to cows (49 ± 
5% vs 38 ± 4%, respectively) and animals exhibiting estrus having greater pregnancy 
success compared to animals that did not exhibit estrus (57 ± 4% vs 32 ± 4% 
respectively).  In addition, there tended to be a treatment by estrus interaction (P = 0.08).  
There was no difference in pregnancy success between treatments among animals that 
exhibited estrus (P > 0.30); however, among animals that did not exhibit estrus 0 μg had 
increased pregnancy success (P ≤ 0.05; 40 ± 6%) compared to 5 μg and 10 μg, which did 
not differ (27 ± 6% and 29 ± 5%, respectively).  In summary, 5 μg of GnRH at CIDR 
removal tended to decrease the interval to estrus and increase expression of estrus among 
heifers but not cows, and both 5 and 10 μg of GnRH at CIDR removal decreased 
pregnancy success among animals that did not exhibit estrus.    
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INTRODUCTION 
Estradiol plays a critical role in fertility among cattle, specifically it has been 
reported that preovulatory estradiol regulates uterine pH (Perry and Perry, 2008), sperm 
transport (Larimore et al., 2015), and endometrial genes that support processes that set up 
the uterine environment for implantation (Bauersachs et al., 2005), all of these favorably 
impact embryo development and survival.  Estradiol is also critical within the ovary as it 
is associated with growth, divergence, ovulation, and eventual regression/atresia of 
follicles (Bodensteiner et al., 1996b).  Classically, estradiol from the follicle is believed 
to be produced via the two-cell two-gonadotropin theory (Fortune and Quirk, 1988).  A 5 
μg dose of GnRH stimulates an LH pulse similar to a physiological pulse (Ginther et al., 
1996).  Multiple small doses of GnRH administered systemically following CIDR 
removal increased circulating concentrations of estradiol (Larimore et al., 2016).  
Estradiol is the primary signal to the hypothalamus to initiate estrus behavior (Vailes et 
al., 1992; Diskin and Sreenan, 2000). 
Cows and heifers that exhibit estrus prior to fixed time AI have increased 
concentrations of estradiol (Perry and Perry, 2008) and increased conception rates versus 
animals that do not exhibit estrus (Richardson et al., 2016).  Variations in expression of 
estrus, interval to estrus, and/or pregnancy success have been hindrances to the successful 
use of protocols to synchronize estrus (Roche and Boland, 1991; Bo et al., 1994).  As a 
result, investigation in ways to manipulate these protocols to favorably impact expression 
of estrus, interval to estrus, and/or conception rates poses an imperative area of research.  
Therefore, the objective of this study was to determine if a single small dose of GnRH (5 
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μg or 10 μg) at CIDR removal would impact expression of estrus, interval to estrus, or 
pregnancy success. 
 
MATERIALS AND METHODS 
All procedures were approved by the South Dakota State University Institutional 
Animal Care and Use Committee. 
 
Experimental Design 
Beef cows and heifers (n = 1620) from five operations in Minnesota and South 
Dakota were randomly assigned to one of three treatment groups (0, 5, or 10 µg GnRH 
analog at CIDR removal).  All animals had their estrous cycle synchronized using the 7-
day CO-Synch + CIDR protocol.  Animals were administered GnRH (100 µg as 2 cc of 
Factrel i.m.; Pfizer Animal Health, Madison, NJ) on day -7, and a CIDR insert (Pfizer 
Animal Health, Madison, NJ) was inserted intravaginally.  On day 0, PGF2α was 
adminstered (PGF2α; 25 mg as 5 cc of Lutalyse i.m.; Pfizer Animal Health, Madison, NJ), 
CIDRs were removed, and GnRH treatments applied.  The animals were visually 
observed for estrus, and inseminated following detection in estrus.  Animals that did not 
exhibit estrus were given 100 μg of GnRH at time of AI, 120 hours post CIDR removal, 
and this was recorded as their interval to estrus.  When animals that did not exhibit estrus 
were included in the analysis with estrus animals, this was termed INTERVAL 2.  Within 
each location, AI bulls and AI technicians were distributed evenly among the three 
treatment groups.  A period of at least 7 days was maintained before cows/heifers were 
turned out with clean-up bulls, for all five herds.  Interval to estrus was calculated for 
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each animal that exhibited estrus (INTERVAL 1).  All cows and heifers from the five 
respective herds were maintained as single groups throughout the entire experiment.  
Across the five herds, the breeding season ranged from 60 to 90 days in length. 
 
Ultrasonography 
Pregnancy diagnoses were conducted between 30 and 70 days following artificial 
insemination via transrectal ultrasonography using an Aloka 500V ultrasound with a 7.5 
MHz transrectal linear probe (Aloka, Wallingford, CT), and crown-rump length was used 
to determine fetal age.   
 
Statistical Analysis 
Differences in interval to estrus were analyzed by analysis of variance using the 
PROC MIXED procedure of SAS (SAS Inst. Inc., Cary, NC).  When the F statistic was 
significant (P < 0.05), mean separation was performed using least significant differences 
(Means ± SEM, Snedecor and Cochran, 1989).  Differences were considered to be 
significant when P ≤ 0.05 and a tendency when P > 0.05 but P ≤ 0.10.  Difference is 
pregnancy success between treatments were analyzed as binomial distributions in the 
GLIMMIX procedure of SAS with herd included as a random variable.  The statistical 
model for expression of estrus included treatment, age (heifer or cow), and the treatment 
by age interaction.  The statistical model for pregnancy included treatment, estrus and age 
and all 2- and 3-way interactions.  Differences were considered to be significant when P 
≤ 0.05 and a tendency when P > 0.05 but P ≤ 0.10. 
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RESULTS 
Interval to Estrus (INTERVAL 1) 
There was an effect of age (P < 0.0001; Figure 4), a weak tendency for an effect 
of treatment (P = 0.11; Figure 5), and a treatment by age interaction (P = 0.05; Figure 6), 
on INTERVAL 1.  Heifers had a shorter interval to estrus compared to cows (50 h ± 1.1 h 
vs 54 ± 1 h, respectively).  Furthermore, heifers treated with 5 μg of GnRH at CIDR 
removal tended to have a shorter interval to estrus (P = 0.07; 47 ± 1.4 h) compared to 0 
μg (50 ± 1.5 h) and did have a shorter interval compared to 10 μg (P < 0.01; 52 ± 1.5 h).  
There were no differences between treatments in interval to estrus among cows (P ≥ 
0.34). 
 
Interval to Estrus (INTERVAL 2) 
 When animals that did not exhibit estrus were included in the analysis at 120 
hours (INTERVAL 2), there was an effect of age (P = 0.03; Figure 7), and treatment (P < 
0.0001; Figure 8), however there was no treatment by age interaction (P = 0.50; Figure 9) 
on interval to estrus.  Heifers had a shorter interval to estrus compared to cows (70 h vs 
73 h, respectively).  When all animals were included in the analysis, animals 
administered the 5 μg treatment had a shorter (P = 0.05) interval to estrus compared to 
the 0 μg treatment (68 ± 1.3 h vs 71 ± 1.3 h, respectively), and both the 5 μg and the 0 μg 
treated animals had shorter (P ≤ 0.02) intervals to estrus compared to the 10 μg (76 ± 1.3 
h) treatment of GnRH.  
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Expression of Estrus 
Treatment (P < 0.001), but not age (P = 0.96) or treatment by age (P = 0.74) 
influenced expression of estrus.  The 5 μg treatment of GnRH following CIDR removal 
tended to have more animals in estrus (P = 0.10; 79 ± 4%) compared to 0 μg (74 ± 5%), 
and 10 μg which had fewer animals in estrus compared to either of the other treatments 
(P < 0.04; 68 ± 6%).  There was no difference in expression of estrus between heifers and 
cows (74 ± 1% vs 74 ± 0.5%, respectively). 
 
Pregnancy Success 
Age (P < 0.01) and expression of estrus (P < 0.0001) influenced pregnancy 
success with heifers having greater pregnancy success compared to cows (49 ± 5% vs 38 
± 4%, respectively) and animals exhibiting estrus having greater pregnancy success 
compared to animals that did not exhibit estrus (57 ± 4% vs 32 ± 4%, respectively).  
There was no difference in pregnancy success between treatments (P = 0.22; Figure 13).  
There tended to be a treatment by estrus interaction (P = 0.08; Figure 14).  There was no 
difference in pregnancy success between treatments among animals that exhibited estrus 
(P ≥ 0.30); however, among animals that did not exhibit estrus the 0 μg treatment had 
increased pregnancy success (P ≤ 0.05; 40 ± 6%) compared to 5 μg and 10 μg which did 
not differ (27 ± 6% and 29 ± 5%, respectively).   
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Figure 4.  Interval to estrus (h) following CIDR removal for heifers and cows that 
exhibited estrus (P < 0.0001).  
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Figure 5.  Interval to estrus (h) following CIDR removal for 0, 5, and 10 µg GnRH for 
animals that exhibited estrus (P = 0.11).  
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Figure 6.  Treatment by age interaction on interval to estrus (h) following CIDR removal 
for animals that exhibited estrus. 
abc
Superscripts differ (P < 0.05), similar superscripts 
with asterisks (*) represent tendencies (P > 0.05 but P ≤ 0.10). 
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Figure 7.  Interval to estrus (h) following CIDR removal for heifers and cows when 
animals that did not exhibit estrus were included (P = 0.03).  
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Figure 8.  Interval to estrus (h) following CIDR removal for 0, 5, and 10 µg GnRH when 
animals that did not exhibit estrus were included (P < 0.0001), 
abc
Superscripts differ (P < 
0.05). 
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Figure 9.  Treatment by age interaction on interval to estrus (h) following CIDR removal 
when animals that did not exhibit estrus were included (P = 0.50). 
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Figure 10.  Expression of estrus of animals treated with 0, 5, and 10 µg GnRH (P < 
0.001).  There was no effect of age (P = 0.96) or treatment by age (P = 0.74) on 
expression of estrus when all animals were included.  
ab
Superscripts differ (P < 0.05), 
similar superscripts with asterisks (*) represent tendencies (P > 0.05 but P ≤ 0.10). 
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Figure 11.  Pregnancy success among heifers and cows when all animals were included 
(P < 0.01). 
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Figure 12.  Pregnancy success of animals that did and did not exhibit estrus (P < 0.0001). 
There was no estrus by age interaction (P = 0.51) for pregnancy success.  
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Figure 13.  Pregnancy success of the three treatment groups when all animals were 
included (0, 5, and 10 µg GnRH) (P = 0.22).  There was no treatment by age interaction 
(P = 0.40) for pregnancy success. 
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Figure 14.  Treatment by estrus interaction on pregnancy success of heifers and cows (P 
< 0.08), 
abc
Superscripts differ (P < 0.05), similar superscripts with asterisks (*) represent 
tendencies (P > 0.05 but P ≤ 0.10). 
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DISCUSSION 
 Animals that exhibited estrus prior to fixed time AI had increased conception 
rates versus animals that did not exhibit estrus (Richardson et al., 2016), and variations in 
expression of estrus, interval to estrus, and/or pregnancy success have been hindrances to 
the successful use of protocols to synchronize estrus (Roche and Boland, 1991; Bo et al., 
1994).  In the current study, heifers had a shorter interval to estrus compared to cows.  
When utilizing the 7 day CO-Synch + CIDR protocol, at time of CIDR removal and 
prostaglandin F2 injection, follicles are in the growing phase (Lussier et al., 1987; 
Ginther et al., 1996).  Furthermore, heifers have shorter follicular waves compared to 
cows, so at the time of prostaglandin F2 injection follicles of heifers are in a more 
advanced stage of growth resulting in a shorter interval to expression of estrus and 
ovulation compared to cows (Adams, 1998).  Among heifers that exhibited estrus, those 
treated with 5 μg of GnRH at CIDR removal tended to have a shorter interval to estrus 
compared to those treated with 0 μg and did have a shorter interval to estrus compared to 
those treated with 10 μg.  There were no differences in interval to estrus observed among 
the cows that exhibited estrus.  Estradiol is the primary signal for the initiation of 
standing estrus (Allrich, 1994), and administration of physiological doses (5 g) 
increased circulating concentrations of estradiol (Larimore et al., 2016). 
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Previous research has also reported that the distribution of expression of estrus 
following CIDR removal when implementing the 7 day CO-Synch + CIDR protocol 
ranged from 36 to 120 hours (Busch et al., 2008; Wilson et al., 2010).  It is unclear why 
some growing follicles produce more estradiol than others (Jinks et al., 2013; Perry et al., 
2014).  When all animals were included in the analysis, 5 μg of GnRH at CIDR removal 
shortened the interval to estrus compared to animals that did not receive GnRH (0 μg), 
and both the 5 μg and 0 μg treatments had shorter interval to estrus compared to the 10 μg 
treatment.  Therefore, the additional LH pulse stimulated by the 5 μg dose of GnRH 
following CIDR removal likely positively contributed to estradiol production, allowing 
animals to reach concentrations of estradiol sufficient enough to initiate standing estrus 
sooner than their counterparts. 
Increased LH pulsatility increased estradiol production (Fortune et al., 2001), and 
5 μg of GnRH administered systemically elicited an LH pulse similar to a physiological 
pulse which positively contributed to LH pulsatility (Ginther et al., 1996).  Thus in the 
current study, the additional physiological pulse of LH likely resulted in the shorter 
interval to estrus and increased expression of estrus, seen in animals treated with 5 μg of 
GnRH.  Cattle continuously infused with GnRH (2 µg, i.v.) were reported to have 
blocked LH pulsatile secretion as a result of pituitary desensitization and GnRH receptor 
down regulation (Vizcarra et al., 1997).  Thus the difference in the response observed 
between the 5 μg treatment and the 10 μg treatment, might be overstimulation with the 
increased dose of GnRH. 
In this study, animals that exhibited estrus had increased pregnancy success 
compared to animals that did not exhibit estrus, which agrees with previous research by 
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Richardson et al. (2016) who reported that cows exhibiting estrus prior to fixed-time AI 
had increased pregnancy success compared to cows that did not exhibit estrus.  Further, 
heifers had increased pregnancy success compared to cows.  Small doses of GnRH 
following CIDR removal did not impact pregnancy success, however, among animals 
that did not exhibit estrus the 0 μg treatment had increased pregnancy success compared 
to 5 μg and 10 μg, which did not differ.  In this instance, the extra LH pulse as a result of 
the supplemental GnRH dose was likely inducing animals that would have exhibited 
estrus to have a shorter interval to estrus and increased expression of estrus, leaving those 
animals that would not respond, explaining why pregnancy success was decreased in the 
GnRH treatment groups compared to control (0 μg). 
In conclusion, animals that exhibited estrus had greater pregnancy success 
compared to animals that did not.  Supplementation of a small dose (5 g) of GnRH at 
CIDR removal during the 7-day CO-Synch + CIDR protocol shortened the interval to 
estrus and increased expression of estrus.  Care must be taken not to administer too large 
of a dose (10 g) as overstimulation may occur and have negative effects on estrus and 
pregnancy success.   
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CHAPTER 4 
INFLUENCE OF SMALL DOSES OF GnRH FOLLOWING CIDR REMOVAL ON 
REPRODUCTIVE PARAMETERS IN BEEF CATTLE SUBJECTED TO A FIXED-
TIME AI PROTOCOL 
ABSTRACT 
Animals that exhibit estrus prior to fixed-time artificial insemination have 
increased circulating concentrations of estradiol and greater conception rates compared to 
those that do not.  Thus, when using a fixed-time AI protocol it is necessary to maximize 
expression of estrus in order to achieve maximum conception rates.  Previous research 
has reported multiple small doses of systemically administered GnRH after CIDR 
removal increased estradiol concentrations.  Therefore, our objective was to determine if 
small doses of GnRH following CIDR removal would impact estradiol concentrations, 
expression of estrus, or pregnancy success in beef cattle subjected to a fixed-time AI 
protocol.  Beef cows and heifers (n = 247) were synchronized using the 7-day CO-Synch 
+ CIDR protocol and were evenly assigned to one of three treatment groups [0 µg GnRH 
at CIDR removal (0 µg); 10 µg GnRH at CIDR removal (10 µg), or 5 µg at CIDR 
removal plus 5 µg 12 h later (5 + 5 µg)].  Animals were visually observed for estrus and 
artificially inseminated 55 (heifers) or 60 (cows) hours following CIDR removal.  Blood 
samples were collected beginning at CIDR removal and every 12 hours until time of AI.  
Data were analyzed using the GLIMMIX procedure of SAS with estrus, treatment, and 
age as independent variables for pregnancy success, and treatment and age as 
independent variables for expression of estrus.  Estradiol concentrations were analyzed 
using analysis of repeated measures in the MIXED procedure of SAS.  Concentrations of 
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estradiol were not influenced by treatment (P = 0.66) or a treatment by time interaction 
(P = 0.87), but were influenced by time (P < 0.0001).  Estradiol concentrations increased 
from CIDR removal to 48 hours after CIDR removal and then were decreased at the time 
of AI.  Expression of estrus was not influenced by age (P = 0.31), or treatment (P = 
0.60); however, there was a treatment by age interaction (P < 0.01) for expression of 
estrus.  For animals administered the 5 + 5 μg treatment, expression of estrus was 
increased (P < 0.01) among heifers compared to cows (84 ± 3% vs 70 ± 3%, 
respectively).  Pregnancy success was influenced by estrus (P < 0.01), treatment (P = 
0.02), and a treatment by estrus (P < 0.01) interaction, but was not influenced by age (P 
= 0.91), treatment by age (P = 0.83), or treatment by estrus by age (P = 0.94).  Animals 
that exhibited estrus had increased pregnancy success compared to animals that did not 
exhibit estrus (67 ± 2% vs 41 ± 7% respectively).  Animals administered the 5 + 5 µg 
treatment had increased pregnancy success (P ≤ 0.05; 69 ± 6%) compared to animals 
administered the 0 µg and 10 µg treatments which did not differ (53 ± 6% vs 41 ± 8%, 
respectively).  Pregnancy success was similar (P ≥ 0.27) between animals that did and did 
not exhibit estrus for animals administered the 0 µg and 5 + 5 µg treatments.  For animals 
administered the 10 µg treatment, conception rates were decreased (P < 0.01) among 
animals that did not exhibit estrus compared to animals that exhibited estrus.  In 
conclusion, the 5 + 5 µg treatment did not impact concentrations of estradiol or 
expression of estrus, but did improve pregnancy success of beef cattle subjected to a 
fixed-time AI protocol.   
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INTRODUCTION 
 
 Artificial insemination allows producers to introduce new genetics into their herd 
and, when coupled with synchronization protocols it allows condensing of their calving 
season and production of a more uniform calf crop.  In order to have increased adoption 
of AI in the beef industry, synchronization protocols need to be easy to administer, 
effectively induce expression of estrus and ovulation, and lastly contribute positively to 
pregnancy success rates.  Fixed-time AI protocols are designed to induce ovulation; 
however, in order for these protocols to be adopted they must produce pregnancy rates 
similar to those synchronization protocols focused on estrus detection. 
Cattle that exhibit estrus prior to fixed-time AI have increased circulating 
concentrations of estradiol (Perry and Perry, 2008) and increased conception rates 
compared to those that do not (Richardson et al., 2016).  Therefore in order to maximize 
conception rates to fixed-time AI it is necessary to improve expression of estrus.  Cattle 
can exhibit estrus up to 5 days (120 h) following CIDR removal (Stevenson et al., 2000; 
Busch et al., 2008; Wilson et al., 2010; Patterson et al., 2013), however many fixed time 
artificial insemination protocols recommend inseminating heifers and cows between 54 
and 72 hours following CIDR removal.  Thus, variations in interval to estrus, expression 
of estrus, and pregnancy success have been hindrances to the successful implementation 
of FTAI synchronization protocols (Roche and Boland, 1991; Bo et al., 1994) and prove 
to be an area where more research is needed.   
Gonadotropin releasing hormone injections (100 μg, i.m.) administered during 
synchronization protocols can induce ovulation of small dominant follicles that have not 
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produced sufficient concentrations of estradiol to induce estrus (Jinks et al. 2013; Perry et 
al., 2014).  Supplementation of estradiol cypionate during the preovulatory period 
increased pregnancy rates in cows induced to ovulate smaller dominant follicles, but had 
no influence when large follicles ovulated (Jinks et al., 2013).  Since estradiol cannot be 
used in production settings to increase estradiol concentrations and expression of estrus, 
investigation in methods to manipulate the estrous cycle and enhance estradiol production 
and expression of estrus are imperative areas of research.   
Gonadotropin releasing hormone has been reported to favorably impact multiple 
factors contributing to reproduction, either directly or indirectly through gonadotropin 
secretion and subsequent estradiol production.  A 5 μg dose of GnRH was reported to 
stimulate an LH pulse similar to that of a physiological pulse (Ginther et al., 1996).  
Furthermore, LH pulsatility stimulated estradiol production by ovarian follicles, and 
increased LH pulsatility further increased estradiol production (Fortune et al., 2001).  
Cows and heifers administered small doses of GnRH following CIDR removal were 
reported to have increased estradiol concentrations (Larimore et al., 2016), and increased 
preovulatory estradiol was reported to positively impact uterine pH (Perry and Perry, 
2008), endometrial gene expression favorable to implantation (Bauersachs et al 2005), 
and sperm transport (Bauersachs et al., 2005; Perry and Perry, 2008; Larimore et al., 
2015).  Thus indicating small doses of GnRH administered systemically may be a useful 
tool in increasing preovulatory estradiol and its associated favorable effects on 
reproduction.  Therefore, the objective of this study was to determine if small doses of 
GnRH administered systemically following CIDR removal would impact estradiol 
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concentrations, expression of estrus, or pregnancy success in beef cattle subjected to a 
fixed-time AI protocol.   
 
MATERIALS AND METHODS 
All procedures were approved by the South Dakota State University Institutional 
Animal Care and Use Committee. 
 
Experimental Design 
Beef cows and heifers (n = 247) at South Dakota State University beef breeding 
unit and cow calf unit (two breeding seasons) were assigned evenly to one of three 
treatment groups [0 µg GnRH as Factrel (0 µg), 10 µg GnRH as Factrel (10 µg), or 5 µg 
GnRH as Factrel at CIDR removal (d 0), plus 5 µg 12 hours later (5 + 5 µg)] based on 
breed, age, AI sire, and calving interval.  The animals were synchronized using the 7-day 
CO-Synch + CIDR protocol.  Animals were administered GnRH (100 µg as 2 cc of 
Factrel i.m.; Pfizer Animal Health, Madison, NJ) on day -7, and a CIDR insert (Pfizer 
Animal Health, Madison, NJ) was inserted intravaginally.  On day 0, PGF2α was 
adminstered (PGF2α; 25 mg as 5 cc of Lutalyse i.m.; Pfizer Animal Health, Madison, NJ), 
and CIDRs were removed, at this time animals were administered one of the three GnRH 
treatments (0 µg, 10 µg, or 5 + 5 µg) and EstroTect patches (Western Point, Inc., Apple 
Valley, MN) were applied to assist with detection of estrus.  Cows and heifers at the 
SDSU cow calf unit were artificially inseminated 54 ± 2 (heifers) or 60-66 (cows) hours 
following CIDR removal (FTAI) and administered GnRH (100 µg as 2 cc Factrel i.m.; 
Pfizer Animal Health, Madison, NJ).  One inseminator artificially inseminated all animals 
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with semen from one of eight bulls, which were evenly distributed among treatments.  
Cows and heifers were maintained separate from bulls for 30 days.  Animals with greater 
than half of their patch rubbed off were documented as having exhibited standing estrus.  
All cows and heifers at their respective units were maintained as single groups 
throughout the experiment. 
 
Ultrasonography 
Pregnancy diagnoses were conducted approximately 30 and 90 days following 
artificial insemination via transrectal ultrasonography using an Aloka 500V ultrasound 
with a 7.5 MHz transrectal linear probe (Aloka, Wallingford, CT).  This study was 
conducted over two breeding seasons.   
 
Blood Sampling and Radioimmunoassay 
Blood samples were collected by jugular venipuncture into 10 mL vacutainer 
tubes (Fisher Scientific, Pittsburgh, PA), but blood collections were conducted differently 
between years.  In year 1, blood samples were collected at CIDR removal (day 0) and 
every 12 hours up until time of AI or 60 h.  In year 2, blood samples were collected at 
CIDR removal (day 0), and at time of AI, 54 ± 2 hours (heifers) and 60-66 hours (cows) 
after CIDR removal.   
Blood was allowed to coagulate at room temperature, stored at 4˚C for 24 hours, 
and centrifuged at 1,200 x g for 30 minutes at 4˚C.  Serum was collected and stored 
at -20˚C until radioimmunoassays (RIA) were performed.  Radioimmunoassays were 
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performed to determine estradiol-17β concentrations using methods described by Perry 
and Perry (2008). 
 
Statistical Analysis 
 Circulating concentrations of estradiol were analyzed by analysis of repeated 
measures using the MIXED procedure of SAS as described by Littell and coworkers 
(1998).  All covariance structures were modeled in the initial analysis.  The indicated best 
fit covariance structure, compound symmetry, was used for the final analysis.  The model 
included the independent variables of treatment, time, and treatment by time.  The effect 
of treatment was analyzed using animal within treatment as the error term, and effects of 
time and any interaction were analyzed using the residual as the error term.  Since 
expression of estrus and pregnancy status are binomial distributions, the proportion of 
animals in each classification were analyzed as binomial distributions in the GLIMMIX 
procedure of SAS.  The statistical model for expression of estrus included treatment, age 
(heifer or cow), and the treatment by age interaction.  The statistical model for pregnancy 
included treatment, estrus and age and all 2- and 3-way interactions.  Differences were 
considered to be significant when P ≤ 0.05 and a tendency when P > 0.05 but P ≤ 0.10.  
 
RESULTS 
Estradiol Concentration 
Concentrations of estradiol were not influenced by treatment (P = 0.66; Figure 
15) or a treatment by time interaction (P ≥ 0.68; Figures 16-18), but were influenced by 
57 
time (P < 0.0001; Figure 19).  Estradiol concentrations increased from CIDR removal to 
48 hours after CIDR removal (2.44 ± 0.18 to 6.0 ± 0.34 pg/mL from 0 h to 48 h) and then 
were decreased at the time of AI (3.44 ± 0.18 pg/mL).  When animals that exhibited 
estrus and those that did not were analyzed separately, concentrations of estradiol were, 
again, not influenced by treatment (P ≥ 0.74) or a treatment by time interaction (P ≥ 
0.69), but were influenced by time (P < 0.01).  For animals that exhibited estrus, estradiol 
concentrations increased from CIDR removal to 48 hours after CIDR removal (2.49 ± 
0.20 to 7.07 ± 0.43 pg/mL from 0 h to 48 h; Figure 20) and then were decreased at time 
of AI (3.50 ± 0.20 pg/mL).  The same pattern was not observed for the animals that did 
not exhibit estrus, concentrations of estradiol were lowest at time of CIDR removal (2.19 
± 0.32; P < 0.03) compared to all other time points, however, there were no significant 
differences (P ≥ 0.44) in concentrations of estradiol from 12 h to time of AI (Figure 21). 
 
Expression of Estrus 
Expression of estrus was not influenced by treatment (P = 0.60; Figure 22) or age 
(P = 0.31; Figure 23); however, it was influenced by a treatment by age interaction (P < 
0.01; Figure 24).  Expression of estrus was similar (P ≥ 0.24) between cows and heifers 
administered the 0 and 10 μg treatments.  However, for animals administered the 5 + 5 μg 
treatment, expression of estrus was increased (P < 0.01) among heifers compared to 
cows. 
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Pregnancy Success 
Pregnancy success was influenced by estrus (P < 0.01; Figure 25), treatment (P = 
0.02; Figure 26), and a treatment by estrus (P < 0.01; Figure 27) interaction, but was not 
influenced by age (P = 0.91; Figure 28), treatment by age (P = 0.83; Figure 29), or 
treatment by estrus by age (P = 0.94).  Animals that exhibited estrus had increased 
pregnancy success compared to animals that did not exhibit estrus (67 ± 2% vs 41 ± 7%, 
respectively).  Animals administered the 5 + 5 µg treatment had increased pregnancy 
success (P ≤ 0.05; 69 ± 6%) compared to animals administered the 0 µg and 10 µg 
treatments which did not differ (53 ± 6% vs 41 ± 8%, respectively).  Pregnancy success 
was similar (P ≥ 0.27) between animals that did and did not exhibit estrus for animals 
administered the 0 µg and 5 + 5 µg treatments.  However, for animals administered the 
10 µg treatment, conception rates were decreased (P < 0.01) among animals that did not 
exhibit estrus compared to animals that exhibited estrus (Figure 27).   
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Figure 15.  Serum concentrations of estradiol (pg/mL) for all animals treated with 0, 5 + 
5, or 10 µg of GnRH at CIDR removal (P = 0.66). 
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Figure 16.  Treatment by time interaction on serum estradiol concentrations (pg/mL) for 
all animals (P = 0.86). 
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Figure 17.  Treatment by time interaction on serum estradiol concentrations (pg/mL) for 
animals that exhibited estrus (P = 0.68). 
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Figure 18.  Treatment by time interaction on serum estradiol concentrations (pg/mL) for 
animals that did not exhibit estrus (P = 0.95). 
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Figure 19.  Serum concentrations of estradiol for all animals (pg/mL) starting at 0 hours 
post CIDR removal to time of AI (P < 0.0001). 
abcde
Supercripts differ (P ≤ 0.05), similar 
superscripts with asterisks (*) represent tendencies (P > 0.05 but P ≤ 0.10). 
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Figure 20.  Serum concentrations of estradiol for estrus animals (pg/mL) starting at 0 
hours post CIDR removal to time of AI (P < 0.0001). 
abcde
Supercripts differ (P ≤ 0.05), 
similar superscripts with asterisks (*) represent tendencies (P > 0.05 but P ≤ 0.10). 
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Figure 21.  Serum concentrations of estradiol for no estrus animals (pg/mL) starting at 0 
hours post CIDR removal to time of AI (P < 0.0001). 
ab
Supercripts differ (P < 0.05). 
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Figure 22.  Expression of estrus of animals treated with 0, 5 + 5, and 10 µg of GnRH at 
CIDR removal (P = 0.60).   
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Figure 23.  Expression of estrus among heifers and cows (P = 0.31).   
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Figure 24.  Treatment by age interaction on expression of estrus (P < 0.01). 
ab
Superscripts 
differ (P ≤ 0.05).  
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Figure 25.  Pregnancy success among animals that did and did not exhibit estrus (P < 
0.01). 
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Figure 26.  Pregnancy success among animals treated with 0, 5 + 5, and 10 μg of GnRH 
following CIDR removal (P < 0.02). 
ab
Supercripts differ (P ≤ 0.05). 
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Figure 27.  Treatment by estrus interaction for pregnancy success (P < 0.01).  
abcd
Superscripts differ (P ≤ 0.05).  
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Figure 28.  Pregnancy success among heifers and cows (P = 0.91). 
 
 
 
 
 
 
 
0
10
20
30
40
50
60
70
80
90
100
Heifers Cows
P
R
EG
N
A
N
C
Y
 R
A
TE
, %
73 
 
Figure 29.  Treatment by age interaction for pregnancy success (P = 0.83). 
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DISCUSSION  
Estradiol plays a critical role in the initiation of estrus and the ovulatory cascade 
(Allrich, 1994), sperm transport (Larimore et al., 2015), and regulation of uterine 
environment and embryo survival (Perry and Perry, 2008; Jinks et al., 2013).  Cows and 
heifers that express estrus prior to FTAI have increased estradiol concentrations (Perry 
and Perry, 2008) and increased pregnancy success compared to those that do not exhibit 
estrus (Richardson et al., 2016).  
 Estradiol production is believed to occur via the two-cell two-gonadotropin theory 
(Fortune and Quirk, 1988), and increased estradiol production is stimulated by increased 
LH pulsatility (Fortune et al., 2001).  A 5 μg dose of GnRH administered systemically 
has been reported to elicit an LH pulse similar to a physiologic pulse and stimulated an 
increase in estradiol similar to what is observed with a naturally occurring pulse (Ginther 
et al., 1996).  Furthermore, in a study by Larimore et al. (2016) multiple small doses (5 
μg) of GnRH stimulated increased estradiol concentrations, specifically via increased LH 
pulsatility.  In this study supplementing 5 + 5 μg or 10 μg of GnRH at CIDR removal did 
not impact circulating estradiol concentrations.  However, estradiol concentrations did 
increase from CIDR removal (0 h) to 48 hours and then were decreased at time of AI.  At 
time of AI all animals were administered GnRH (100 μg) which would result in an LH 
surge, following an LH surge, aromatase activity is down regulated resulting in decreased 
circulatory and follicular estradiol concentrations (Komar et al., 2001). 
When circulating concentrations of estradiol were analyzed separately for animals 
that exhibited estrus and those that did not exhibit estrus, the supplemental GnRH 
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treatment (5 + 5 μg or 10 μg at CIDR removal), again, did not produce significant 
differences.  When animals that exhibited estrus were analyzed separately, circulating 
estradiol concentrations peaked at a higher concentration over time, this is supported by 
previous research which reported estrus animals had increased circulating concentrations 
of estradiol compared to animals that do not exhibit estrus (Perry and Perry, 2008).  For 
animals that did not exhibit estrus there was a different pattern observed in circulating 
estradiol concentrations over time.  Estradiol concentrations increased from CIDR 
removal (0 h) to 12 hours later but did not change significantly after 12 hours. 
When it came to expression of estrus there was a treatment by age interaction.  
Specifically, among animals treated with the 5 + 5 μg dose of GnRH at CIDR removal, 
heifers responded more favorably compared to cows, with increased expression of estrus.  
There were no significant differences between treatments among cows.  The 5 + 5 μg 
contributing to more LH pulsatility, whereas 10 μg treatment had decreased expression of 
estrus.  A dose of 10 μg might be over stimulating and potentially negatively impacting 
estradiol production, similar to what was observed in a previous study by Larimore et al. 
(2016) where multiple small doses (5 μg) of GnRH were administered and initially 
positively contributed to estradiol production however after 8 hours estradiol production 
was reduced to baseline.  This over-stimulatory effect was also noted in another study 
where cattle continuously infused with GnRH (2 µg, i.v.) had LH pulsatile secretion 
blocked and GnRH receptor down regulation (Vizcarra et al., 1997). 
In this study, small doses of GnRH following CIDR removal positively impacted 
pregnancy success, specifically the 5 + 5 μg dose of GnRH had increased pregnancy 
success compared to the 0 μg and 10 μg treatments.  Overall among animals that 
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exhibited estrus prior to FTAI, both the 5 + 5 μg and the 10 μg of GnRH following CIDR 
removal had or tended to have increased pregnancy success compared to estrus animals 
in the 0 μg group, this could be a result of GnRH stimulating an LH pulse, which could 
be modulating estradiol concentrations enough to induce favorable conditions, altered 
uterine pH, increased expression of endometrial genes supportive of implantation, and 
sperm transport (Bauersachs et al., 2005; Larimore et al. 2015; Perry and Perry, 2008).  
Among animals that did not exhibit estrus the 5 + 5 μg induced favorable pregnancy 
success, however the 10 μg treatment lead to decreased pregnancy success.   
In addition to stimulating LH pulses GnRH may also be impacting pregnancy 
success through other mechanisms.  Among humans, GnRH and its analogs were 
reported to increase binding of spermatozoa to the zona pellucida (Morales and Llanos, 
1996).  Gonadotropin releasing hormone agonists were also reported to increase the 
cleavage rates of bovine oocytes in vitro (Funston and Seidel, 1995).  Overall GnRH 
seems to play a vital role both directly and indirectly in the processes involved with 
successful fertilization.  In conclusion, supplementation with small doses of GnRH 
following CIDR removal (5 + 5 µg) did not impact circulating concentrations of estradiol 
or expression of estrus, but favorably impacted conception rates.      
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CHAPTER 5 
DIFFERENCES IN ABUNDANCE OF GnRH-I AND GnRH-II AMONG BOVINE 
ANTRAL FOLLICLES  
ABSTRACT 
  
Estradiol plays a critical role in fertility among cattle, specifically it has been 
reported that preovulatory estradiol regulates uterine pH, sperm transport, and uterine 
secretions that impact embryo development and survival.  Both Gonadotropin-releasing 
hormone (GnRH) and GnRH receptors have been reported in granulosa cells of cattle, 
and among other species GnRH has been reported to modulate follicular steroidogenesis.  
Thus, the objective of the current study was to determine changes in the relative 
abundance of GnRH-I and GnRH-II mRNA within granulosa cells of bovine follicles.  
Beef cows/heifers were synchronized using the CO-Synch protocol and artificially 
inseminated.  On day 16 after insemination animals were transported to a local abattoir.  
Following slaughter ovaries were collected and all follicles were classified as small (< 5 
mm), medium (5 to 10 mm), or large (> 10 mm).  Follicles were aspirated to collect 
follicular fluid and granulosa cells.  Follicles were pooled by size within animal (n = 23, 
16, and 18 for small, medium, and large, respectively).  Follicular fluid concentrations of 
estradiol were determined by radioimmunoassay.  Total cellular RNA was extracted from 
the granulosa cells and RT-PCR was performed to determine relative abundance of 
mRNA for GnRH-I, GnRH-II, and GAPDH.  Data were analyzed using the mixed 
procedure in SAS.  Follicle size influenced concentration of estradiol.  Large follicles had 
increased estradiol (P < 0.0001) compared to small and medium follicles (18,626 ± 2,650 
vs 1,270 ± 2,307 and 8,925 ± 2,763 pg/mL, respectively).  There was no difference (P = 
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0.31) in relative abundance of GnRH-I mRNA among small, medium, or large follicles 
(3.8 ± 0.78, 3.40 ± 0.85, and 1.95 ± 0.94; respectively).  However, relative abundance of 
GnRH-II mRNA was influenced by follicle size (P < 0.05), with greater abundance in 
small follicles (40.97 ± 9.27) compared to medium (6.32 ± 11; P = 0.02) or large (7.85 ± 
11.11; P = 0.02) follicles.  However, there was no difference (P = 0.92) in relative 
abundance between medium and large follicles.  When follicles were classified by 
concentration of estradiol, follicles with the lowest 25% of estradiol had decreased 
(LOWE2; P < 0.0001) concentrations of estradiol (434 ± 1,074 pg/mL) compared to the 
middle 50% (MIDE2; 7,029 ± 961 pg/mL) which was decreased (P < 0.0001) compared 
to the greatest 25% (HIGHE2; 46,423 ± 2,025 pg/mL).  LOWE2 had greater (P < 0.01; 
5.37 ± 0.67) abundance of GnRH-I mRNA compared to MIDE2 and HIGHE2 which did 
not differ (1.85 ± 0.55 and 1.23 ± 1.65, respectively).  Relative abundance of GnRH-II 
mRNA was greater (P < 0.01) in LOWE2 (42.33 ± 9.56) compared to MIDE2 (5.98 ± 
8.90).  HIGHE2 was similar (P ≥ 0.12) to the other two groups (8.90 ± 19.12).  Thus the 
decreased abundance of GnRH-I and GnRH-II mRNA may play a role in increased 
production of estradiol. 
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INTRODUCTION 
 Since the discovery of GnRH three distinct forms have been characterized 
(GnRH-I, GnRH-II, and GnRH-III); however, only GnRH-I and GnRH-II have been 
found in mammals.  Gonadotropin releasing hormone-I is the isoform that is thought to 
work predominantly through the classical hypothalamo-pituitary-gonadal axis to 
stimulate gonadotropin release, while GnRH-II is thought to be associated with sexual 
behavior (Millar, 2005).  There have been many reports on extra-pituitary actions of 
GnRH, those of special interest to reproductive physiologists being actions within the 
gonads.   
Expression of GnRH in the ovary was first characterized in rats (Clayton et al., 
1979; Reeves et al., 1980; Jones et al., 1980).  Expression was next localized to primary, 
secondary, and tertiary follicles in the rat (Clayton et al., 1992; Whitelaw et al., 1995).  
More recently, GnRH-R mRNA expression has been reported in both bovine granulosa 
cells and luteal tissue, specifically small antral follicles were reported to have increased 
GnRH receptor mRNA compared to both medium and large follicles (Ramakrishnappa et 
al., 2003).   
 A GnRH-like protein was identified in bovine follicles, and this protein 
suppressed LH-stimulated accumulation of cAMP in a dose dependent manner (Aten et 
al., 1987).  This GnRH-like protein was found to be in greatest concentrations in the 
granulosa cells (Ireland et al., 1988).  Gonadotropin releasing hormone has been reported 
to have both stimulatory and inhibitory actions on steroidogenesis within the ovary in 
many species such as the rat, humans, pigs and cows (Sharpe, 1982; Janssens et al., 2000; 
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Millar, 2005; Ramakrishnappa et al., 2005).  Furthermore, when a GnRH agonist was 
added to cultured granulosa cells at a concentration of 200 ng/mL it stimulated estradiol 
production, but at concentrations of 500 ng/mL and 1000 ng/mL it decreased estradiol 
production (Ramakrishnappa et al., 2005).  Some large follicles fail to produce elevated 
concentrations of estradiol while some small follicles do produce elevated concentrations 
of estradiol (Jinks et al., 2013; Perry et al., 2014), intra-follicular GnRH may be a 
contributing factor in these variable amounts of estradiol and can directly impact 
steroidogenesis.  Therefore, the objective of this study was to determine the relative 
abundance of GnRH-I and GnRH-II mRNA among bovine antral follicles when 
classifying follicles based on size and based on follicular fluid concentrations of 
estradiol. 
 
MATERIALS AND METHODS 
All procedures were approved by the South Dakota State University Institutional 
Animal Care and Use Committee. 
  
Experimental Design 
Beef cows and heifers (n = 37) at the SDSU Beef Breeding Unit were 
synchronized using a CO-Synch protocol.  Gonadotropin releasing hormone was 
administered (100 µg as 2 cc of Factrel i.m.; Pfizer Animal Health, Madison, NJ) on day 
-9, followed by PGF2α administration (PG; 25 mg as 5 cc of Lutalyse i.m.; Pfizer Animal 
Health, Madison, NJ) on day -2.  On day 0 animals were administered GnRH (100 µg as 
2 cc of Factrel i.m.; Pfizer Animal Health, Madison, NJ) and artificially inseminated.  
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Follicular dynamics and ovulation were characterized by transrectal ultrasonography 
using an Aloka 500V ultrasound with a 7.5 MHz linear probe (Aloka, Wallingford, CT) 
on day -9, 0, and 3.  Animals were monitored for estrus behavior daily with the use of 
EstroTect patches (Western Point, Inc., Apple Valley, MN).  Animals with greater than 
half of their patch rubbed off were documented as having exhibited standing estrus. 
 
Tissue Collection 
Animals were sent to a local abattoir on day 16 following insemination, and 
reproductive tracts were collected immediately following slaughter and kept on ice.  
Ovaries were collected and all visible surface follicles (tertiary follicles containing a fluid 
filled antrum, an oocyte surrounded by multiple layers of granulosa cells, and a theca 
interna and theca externa layer) were counted and classified by size using calipers; small 
(< 5 mm) n = 23, medium (5 to 10 mm) n = 16, and large (> 10 mm) n = 18.  Needle 
aspirations were conducted to collect the follicular fluid and granulosa cells (n = 57 
bovine follicles).  Granulosa cells were separated from the follicular fluid by 
centrifugation, placed in RNase Free tubes (USA Scientific) and snap frozen in liquid 
nitrogen.  Granulosa cell samples were stored in a -80˚C freezer until total RNA was 
extracted.  Follicular fluid samples were diluted to 1:100 and 1:1000 for small and 
medium follicles, and 1:1000 and 1:10000 for large follicles then stored in a -20˚C 
freezer until radioimmunoassays were performed. 
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Radioimmunoassay 
Follicular fluid concentrations of Estradiol 17-β were determined by 
radioimmunoassay (RIA) using the methods described by Perry and Perry (2008).  
Animals were classified as LOWE2 (lowest 25%), MIDE2 (middle 50%), or HIGHE2 
(highest 25%).  Inter- and intra-assay CV were 14.9% and 5.06%, respectively and assay 
sensitivity was 0.4 pg/mL. 
 
RNA Extraction and Real Time RT-PCR 
Total cellular RNA was extracted from granulosa cells using a Qiagen RNeasy 
Plus Mini Kit (Austin, Texas) prior to RNA isolation.  Pure RNA was dissolved in 
nuclease free water, and a spectrophotometer (NanoDrop Technologies, Wilmington, DE) 
was used to determine RNA concentration for each sample.  The RNA samples were then 
stored in a -80˚C freezer.  The RNA was diluted to 70 ng/µl and Real Time RT-PCR was 
performed in duplicate using iScript One-Step RT-PCR Kit with SYBR Green (Bio-Rad 
Laboratories, Inc.) and a Stratagene MX 3000p QPCR machine.  Transcript abundance of 
GnRH-I and GnRH-II was measured using the primers in Table 1, and GAPDH was used 
as the endogenous reference gene.  All of the primers were diluted to a concentration of 
10 µM and all products were verified for identity by sequencing (Iowa State Genomics 
Core).  Each plate contained negative controls to ensure no background contamination 
was occurring.  The PCR program was 10 minutes at 50˚C, 1 minute at 95˚C for melting, 
and 30 seconds at 60˚C for annealing and elongation for 40 cycles.  Base pair size of all 
PCR products was confirmed through gel electrophoresis and the intra-assay CV for all 
primer pairs was < 28%.   
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Statistical Analysis 
Differences in follicular fluid concentrations of estradiol, relative abundance of 
GnRH-I, and relative abundance of GnRH-II were analyzed by analysis of variance using 
the PROC MIXED of SAS (SAS Inst. Inc., Cary, NC).  When the F statistic was 
significant (P < 0.05), mean separation was performed using least significant differences 
(Means ± SEM, Snedecor and Cochran, 1989). Differences were considered to be 
significant when P ≤ 0.05 and a tendency when P > 0.05 but P ≤ 0.10.   
 
RESULTS 
Follicular Fluid Estradiol Concentration 
Estradiol concentrations were influenced by follicle size (P < 0.0001), large 
follicles had increased estradiol (18,626 ± 2,650; Figure 30) compared to medium 
follicles (8,925 ± 2,763 pg/mL) which had increased estradiol compared to small follicles 
(1,270 ± 2,307 pg/mL).  When animals were classified by follicular fluid concentration of 
estradiol (Figure 31), follicles with the lowest 25% of estradiol had decreased (LOWE2, 
P < 0.01) concentrations of estradiol (434 ± 1,074 pg/mL) compared to the middle 50% 
(MIDE2; 7,029 ± 961 pg/mL) which was decreased (P < 0.01) compared to the greatest 
25% (HIGHE2; 46,423 ± 2,025 pg/mL).   
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GnRH-I mRNA Abundance 
There was no difference (P = 0.31; Figure 32) in relative abundance of GnRH-I 
mRNA among small, medium, or large follicles (3.8 ± 0.78, 3.40 ± 0.85, and 1.95 ± 0.94; 
respectively).  When animals were classified by follicular fluid estradiol concentration, 
LOWE2 had greater (P ≤ 0.03; 5.37 ± 0.67) abundance of GnRH-I mRNA compared to 
MIDE2 and HIGHE2 (1.85 ± 0.55 and 1.23 ± 1.65, respectively; Figure 33).   
GnRH-II mRNA Abundance 
 Relative abundance of GnRH-II mRNA was influenced by follicle size (P = 0.02; 
Figure 34), with greatest abundance in small follicles (40.97 ± 9.27) compared to medium 
(6.32 ± 11, P = 0.02) or large follicles (7.85 ± 11.11, P = 0.02).  However, there was no 
difference (P = 0.92) in relative abundance between medium and large follicles.  When 
animals were classified by follicular fluid estradiol concentration, relative abundance of 
GnRH-II mRNA was (P < 0.01) greater in LOWE2 (42.33 ± 9.56) compared to MIDE2 
(5.98 ± 8.90).  HIGHE2 was similar (P ≥ 0.12) to the other two groups (8.90 ± 19.12; 
Figure 35). 
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Gene 
 
Primer 
 
Primer Sequence 
 
 
Fragment 
Size 
 
 
Reference 
GnRH I Forward 
Reverse 
5’-GCAGCTCTGGAAAGTCTGATTG-3’ 
5’-TCCATGCAACCTGGTGTAAGAA-3’ 
170 (Ramakrishnappa et 
al., 2003) 
GnRH II Forward 
Reverse 
5’-TCGGGGGATGATACACCACT-3’ 
5’-TTCAGCGTGCGGGTTTTCTA-3’ 
226 (Ramakrishnappa et 
al., 2003) 
GAPDH Forward  
Reverse 
5’-GATTGTCAGCAATGCCTCCT-3’ 
5’-GGTCATAAGTCCCTCCACGA-3’ 
94 (Han et al., 2006) 
Table 1.  Genes, Primer sequences, and fragment size for genes amplified during Real 
Time RT-PCR. 
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Figure 30.  Follicular fluid estradiol concentrations of small, medium, and large follicles. 
abc
Supercripts differ (P < 0.05). 
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Figure 31.  Follicular fluid estradiol concentrations of LOWE2, MIDE2, and HIGHE2 
follicles.
abc
Supercripts differ (P < 0.05). 
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Figure 32.  Relative abundance of GnRH-I mRNA in granulosa cells of small, medium, 
and large follicles (P = 0.31). 
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Figure 33.  Relative abundance of GnRH-I mRNA in granulosa cells of LOWE2, MIDE2, 
and HIGHE2 follicles.  
ab
Supercripts differ (P < 0.05). 
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Figure 34.  Relative abundance of GnRH-II mRNA in granulosa cells of small, medium, 
and large follicles. 
ab
Supercripts differ (P < 0.05). 
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Figure 35.  Relative abundance of GnRH-II mRNA in granulosa cells of LOWE2, 
MIDE2, and HIGHE2 follicles. 
ab
Supercripts differ (P < 0.05). 
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DISCUSSION 
Estradiol plays a critical role in fertility among cattle, specifically it has been 
reported that preovulatory estradiol regulates uterine pH (Perry and Perry, 2008), sperm 
transport, and uterine secretions that impact embryo development and survival (Jinks et 
al., 2013; Larimore et al., 2015).  Estradiol is the primary signal to the hypothalamus to 
initiate the expression of estrus (Vailes et al., 1992; Diskin and Sreenan, 2000) and is also 
critical within the ovary as it is associated with growth, divergence, ovulation, 
termination, and eventual regression/atresia of follicles (Bodensteiner et al., 1996b).  In a 
study by Perry et al. (2014) follicle diameter had a positive relationship with peak 
concentrations of estradiol, but only among cows that exhibited standing estrus, and 
estradiol increased earlier in cows that exhibited estrus compared to cows that did not.  
Furthermore, cows with greater circulating concentrations of estradiol during the 
preovulatory period had up-regulation of the steroidogenic pathway within the granulosa 
cells and tended to have increased LH pulse frequency immediately following initiation 
of luteal regression with PGF2α compared to cows that did not exhibit estrus.   
Classically, estradiol from the follicle is believed to be produced via “the two-cell 
two-gonadotropin theory” (Liu and Hsueh, 1986; Fortune and Quirk, 1988).  A 5 μg dose 
of GnRH stimulates an LH pulse similar to a physiological pulse (Ginther et al., 1996).  
Further, multiple small doses of GnRH administered systemically following CIDR 
removal increased circulating concentrations of estradiol (Larimore et al., 2016).  
Animals that exhibit estrus prior to a fixed time AI have increased concentrations of 
estradiol (Perry and Perry, 2008) and increased conception rates versus animals that do 
not exhibit estrus (Richardson et al., 2016).  These studies have demonstrated that GnRH 
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can impact estradiol concentrations secondary to gonadotropin release, but whether or not 
that GnRH is having any effect directly at the ovary remains unknown. 
In the present study, relative abundance of GnRH-I and GnRH-II mRNA was 
greater in small follicles as well as in LOWE2 follicles, these results are similar to 
patterns of expression reported by Ramakrishnappa et al. (2003) for GnRH receptor 
mRNA in bovine antral follicles.  Furthermore when a GnRH agonist was added to 
cultured granulosa cells at a concentration of 200 ng/mL it stimulated estradiol 
production, but at concentrations of 500 ng/mL and 1000 ng/mL it decreased estradiol 
production (Ramakrishnappa et al., 2005).  Therefore one could infer that the decreased 
abundance of GnRH-I and II mRNA in medium and large or MIDE2 and HIGHE2 
follicles may play a role in increased production of estradiol.  
Previous studies have also reported GnRH to induce follicular atresia in rats, 
porcine, and human follicular cells (Hsueh et al., 1984; Piquette et al., 1991; Billig et al., 
1994; Whitelaw et al., 1995; Motomura, 1998; Sridaran et al., 1998; Zhao et al., 2000), 
specifically GnRH-R mRNA was highly expressed in atretic follicles of rats during the 
follicular phase (Whitelaw et al., 1995).  In the current study, highly variable amounts of 
GnRH-I and II mRNA were observed in large bovine antral follicles.  The stage of 
follicular development that these follicles were in was not well known, therefore some of 
those large follicles could have been undergoing atresia.  Thus the variable abundance of 
GnRH-I and II mRNA in large follicles could be from some follicles initiating atresia.   
In conclusion, relative abundance of GnRH-I and GnRH-II mRNA in bovine 
granulosa cells was increased in LOWE2 and some of the HIGHE2 follicles, which we 
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speculate to have been undergoing atresia.  Thus the decreased abundance of GnRH-I and 
II in follicles with elevated concentrations of estradiol may indicate that GnRH is capable 
of regulating estradiol production in bovine antral follicles.  Further investigations are 
warranted to determine the specific ways in which GnRH-I and II are impacting estradiol 
production of growing bovine antral follicles and at what specific stages of follicular 
growth those actions are having the most impact.   
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